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ABSTRACT
DESIGN OF DRUG NANO-CARRIERS FOR STUDY OF MULTIDRUG RESISTANCE
IN SINGLE LIVE CELLS
Pavan Kumar Cherukuri
Old Dominion University, 2016
Director: Dr. Xiao-Hong Nancy Xu
Multidrug resistance (MDR) exists in both prokaryotic and eukaryotic cells. MDR
is responsible for ineffective treatment of a wide range of diseases, such as infections
and cancer. The ATP-binding cassette (ABC) membrane transporters (efflux pumps)
are one of the largest and most diverse super-families of membrane proteins found in all
living organisms, ranging from bacteria to humans. All ABC transporters share a
common structure of four core domains; two transmembrane domains (TMD) with
variable sequence and topology and two nucleotide-binding domains (NBD) with
conserved sequences. Conventional methods for the study of the efflux functions are
radioactively labeled substrates and fluorescent dyes, which provide the sum of
accumulation kinetics of a population of cells. Notably, individual cells act independently
of efflux and accumulation kinetics and therefore, the accumulation kinetics of single
cells is lost in such bulk measurements. Furthermore, single fluorophores or
radioisotopes themselves do not possess distinctive size-dependent physicochemical
properties that would allow their sizes to be measured in situ in real time. Therefore,
they cannot serve as various sized pump substrates for the study of size-dependent
efflux function of single membrane transporters in single live cells. This dissertation
focuses on development of single nanoparticle (NP) plasmonic spectroscopy and
design of three different sized drug nano-carriers to study the size-dependent efflux
function of ABC membrane transporters (e.g., MsbA and BmrA) in single live cells, two
model organisms such as E.coli (gram-negative) and B.subtilis (gram-positive) bacterial
cells., aiming to understand and overcome MDR. We designed, synthesized, and
purified silver (Ag) nanoparticles (NPs) with diameters of 2.4 ± 0.7 nm, 13.0 ± 3.1, and
92.6 ± 4.4 nm, functionalized them with monolayer of 11-amino-1-undecanethiol
hydrochloride (MUNH2), and linked them with antibiotics ofloxacin (Oflx) via two-step

reaction process. We determined the conjugation ratio (the number of Oflx molecules
attached to a single NP) of 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm as 8.6x102, 9.4x103,
and 6.5x105 respectively. We characterized single nano-carriers using dark-field optical
microscopy

and

spectroscopy

(DFOMS).

These

drug

nano-carriers

exhibit

photostability, which enabled us to study the size-dependent efflux functions of single
membrane transporters in single live cells in real-time for a desired period of time. Using
these three different sized nano-carriers, we found the size dependent inhibitory effects
of the drug nano-carriers in single live cells, two strains of B.subtilis, WT (normal
expression of BmrA) and ∆BmrA (deletion of BmrA). We have demonstrated that single
plasmonic NPs can serve as unique size-dependent molecular imaging probes to study
efflux functions of single membrane transporters in single live cells in real-time.
Furthermore, we found that the smaller drug nano-carriers are much more
biocompatible than the larger drug nano-carriers. In other words, the larger drug nanocarriers show higher inhibitory effects against the bacterial cells. Thus, the smallest
nano-carriers (2.4 ± 0.7 nm) could be used to study the efflux function of ABC (BmrA)
membrane transporters in single live cells, while the large nano-carriers could be used
to effectively deliver antibiotics that could overcome MDR and enhance antibiotics
efficacy.
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NOMENCLATURE
ΔABM

B.subtlis mutant strain with no expression of BmrA proteins

Ε

Extinction coefficient

λmax

Peak wavelength

µmol

Micromoles

µm

Micrometer

µM

Micromolar

µL

Microliter

ABC

ATP-binding cassette

Ag NPs

Silver Nanoparticles

Ag

Silver

AgMUNH2

Silver nanoparticles functionalized with 11-amino undecanethiol
Hydrochloride

AgMUNHOflx

Silver nanoparticles functionalized with 11-amino undecanethiol
hydrochloride and linked to ofloxacin

Au

Gold

AZT

Aztreonam

C

Concentration

CCD

Charged coupled device used for imaging nanoparticles with high
sensitivity, temporal resolution and spatial resolution

DFOMS

Dark-field optical microscopy and spectroscopy

DI

De-ionized

DLS

Dynamic light scattering

viii
DNA

Deoxyribonucleic acid

EDC

1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide Hydrochloride

EtBr

Ethidium Bromide

FWHM

Full width at half maxima

h

Hour

H2O2

Hydrogen peroxide

HRTEM

High-resolution transmission electron microscopy

LB

Luria medium

LSPRS

Localized surface plasmonic resonance spectra

MΩ

Megaohms

min

Minutes

mL

Milliliter

ms

Millisecond

MIC50

Minimum inhibitory concentration at 50%

MDR

Multidrug resistance pump

MUNH2

11-amino undecanethiol hydrochloride

nM

Nanomolar

nm

Nanometer

ns

Nanosecond

NaBH4

Sodium borohydride

s-NHS

N-hydroxysulfosuccinimide

NBD

Nucleotide-binding domains

NPs

Nanoparticles

OD

Optical Density

Oflx

Ofloxacin

ix
pM

Picomolar

PBS

Phosphate buffer saline

PVP

Polyvinyl pyrrolidine

rcf

relative centrifugal force

s

Seconds

SMNOBS

Single Molecule Nanoparticle Optical probes and biosensors

TEM

Transmission electron microscopy

TMD

Transmembrane domains

UV-vis

Ultraviolet-visible

WT

Wild type
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CHAPTER I
OVERVIEW
Multidrug membrane transporters (efflux pumps) are found in both prokaryotes
and eukaryotes and they can extrude a wide variety of substrates out of cells, leading to
multidrug resistance (MDR) and ineffective treatment of wide range of diseases, from
cancer to infection diseases.1-2 For instance, the adenosine triphosphate (ATP)-binding
cassette (ABC) transporters (e.g., MsbA, BmrA) is one of the largest and most diverse
super-families of membrane transporters found in all living organisms, ranging from
bacteria to humans.1, 3-5 All ABC transporters share a common structure of a four core
domain; two transmembrane domains (TMD) and two nucleotide-binding domains
(NBD).1, 5 Despite extensive studies, many questions about their molecular mechanisms
and functions remain unanswered. The current method for studying the efflux function
includes the use of radioactively labeled substrates (14C and 3H) and fluorescent dyes
(Ethidium bromide or Hoechst dyes) as probes.6-9 These conventional methods enable
to study the accumulation of bulk cells. Notably, individual membrane transporters act
distinctively and so do their efflux pump kinetics. We have demonstrated that efflux
kinetics of single membrane transporters of single live cells can be studied in real-time
using thin-layer total-internal reflection fluorescence microscopy and spectroscopy. 10
However, single fluorophores or radioisotopes themselves do not possess distinctive
size-dependent physicochemical properties that would allow their sizes to be measured
in situ in real time. Therefore, they cannot be used as various sized pump substrates for
the study of size-dependent efflux function of single membrane transporters in single
live cells.

Noble metal nanoparticles, such as Silver nanoparticles (Ag NPs), Gold
nanoparticles (Au NPs) possess unique optical properties, such as localized surface
plasmon resonance (LSPR).11-13 Ag NPs show size-dependent plasmonic optical
properties.11-13 The Ag NPs show orders of magnitude at higher scattering intensity than
the same sized of Au NPs.11-16 Furthermore, single Ag NPs exhibit much higher sizedependent localized surface plasmon resonance (LSPR) spectra than Au NPs.11-16
The journal for this dissertation is ACS Nano
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Therefore, Ag NPs are much more sensitive optical imaging probes for the study of
size-dependent efflux kinetics of membrane transporters in single live cells than the Au
NPs. We have used the size-dependent LSPR spectra (colors) of single Ag NPs to
image the sizes of NPs in solution, single live cells, and embryos at nm resolution in real
time.13, 16-20
Unlike fluorescent probes and semiconductor quantum dots (QDs), these noble
metal NPs show photostability and resist photodecomposition and blinking. They can
serve as optical probes for tracking the transformation of pore sizes of membrane
transporters and the size-dependent transport kinetics of efflux pumps for a desired
period of time.17-19

This dissertation consists of seven chapters. Chapter I, provides a brief overview of
the research background, the significance of this dissertation research, and an outline of
the contents pertaining to each individual chapter.

Chapter II, discusses the synthesis and characterization of stable (non-aggregated)
spherical Ag NPs. We have demonstrated that single Ag NPs resist to photo-bleaching
and they can serve as photostable imaging probes to study efflux kinetics and function
of multidrug membrane transporter in gram-negative bacteria cells (E.coli) at single cell
resolution and over a desired long period of time.

We synthesized and characterized purified and stable Ag NPs (12.3 ± 1.8 nm in
diameter) and used them to study efflux kinetics and function of multidrug membrane
transporters (MsbA). The distinctive LSPR spectra (colors) of single Ag NPs enable us
to distinguish single Ag NPs over cellular membranes, vesicles, and debris and to track
single NPs in and out of single live cells. We found the accumulation and efflux kinetics
of single Ag NPs to be highly dependent on the concentration of Ag NPs and the
presence of pump inhibitors (orthovanadate), demonstrating that single Ag NPs can
serve as probes to study efflux functions of MsbA in single live cells (E.coli).21

3

Figure 1: Schematic illustration of study of efflux kinetics of single MsbA
transporters in single live cells in real-time using LSPR spectra of single Ag
NPs.21

In Chapter III, we studied the dependence of inhibitory effects of drug nanocarriers upon the sizes and doses of the drug nano-carriers and expression level of
membrane transporters. We were aiming to develop drug nano-carriers to evade the
transporters and to achieve high efficacy, and rationally design biocompatible nanocarriers to study efflux function of single membrane transporters. To this end, we
synthesized three different sizes of Ag NPs (2.4 ± 0.7), (13.0 ± 3.1), and (92.6 ± 4.4)
nm. We functionalized these NPs with ofloxacin (Oflx) to produce AgMUNH-Oflx NPs
(drug nano-carriers) by a two-step reaction process. First, a thiol group is used to attach
monolayer of 11-amino-1-undecanethiol hydrochloride (MUNH2) molecules to produce
AgMUNH2 NPs, and in step 2 carboxyl group of Oflx is covalently conjugated with the
amine group of MUNH2 via the peptide bond. We determined the number of Oflx
molecules attached to a single NP (conjugation ratios) as 8.6x102, 9.4 x103, and 6.5
x105. We studied the inhibitory effect of drug nano-carriers against B.subtilis, with
normal expression of BmrA and with deletion of BmrA and found the size and dose
dependent minimum inhibitory concentration of drug nano-carriers, showing 2.4 ± 0.7
nm is less toxic than free Oflx (non-Conjugated with NPs), 13.0 ± 3.1, and 92.6 ± 4.4 nm
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are far more toxic than free Oflx as summarized in Figure 2. In Figure 2 minimum
inhibitory concentrations were 0.165, 0.126, 0.078, and 0.013 µM for 2.4 ± 0.7 nm, free
Oflx, 13.0 ± 3.1 nm, and 92.6 ± 4.4 nm and are incubated with different concentrations
of three sized drug nano-carriers and Oflx alone. We also conducted control
experiments and found that AgMUNH2 NPs (nano-carriers) are biocompatible and show
insignificant inhibitory effect against both strains of BmrA.22

Figure 2: Schematic illustration of MIC of drug nano-carriers in B.subtilis using
DFOMS. 22
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In Chapter IV, we studied the efflux function of BmrA in both strains of B.subtilis
(WT and a devoid pump ΔBmrA) using AgMUNH-Oflx (drug nano-carriers) and
AgMUNH2 (nano-carrier) NPs. We found that single AgMUNH-Oflx NPs and AgMUNH2
NPs passively diffused into the live cells and were extruded out of live cells as shown in
Figure 3. We found that accumulation rates of NPs inside the cells highly depends upon
the types of NPs, doses of NPs, and expression of BmrA, demonstrating that NPs can
serve as imaging probes to study efflux function of BmrA and to design effective
therapy.23

Figure 3: Schematic illustration of study of efflux kinetics of single B.subtilis
transporters in single live cells in real-time using LSPR spectra of single 2.4 ± 0.7
nm AgMUNH-Oflx NPs.23

In Chapter V, we studied efflux function of BmrA in both strains of B.subtilis (WT
and ΔBmrA) using 13.0 ± 3.1 nm AgMUNH-Oflx NPs and AgMUNH2. We found that
single AgMUNH-Oflx NPs and AgMUNH2 NPs passively diffused into the live cells and
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were extruded out of live cells. We found a higher number of intracellular AgMUNH2
NPs than AgMUNH-Oflx NPs, indicating that the cells highly depend upon the types of
NPs as shown in Figure 4. We also found that accumulation rates of NPs inside the
cells highly depend upon the doses of NPs indicating that rapid efflux occurs when
functionalized with the Oflx drug doses of NPs, and expression of BmrA, demonstrating
that NPs can serve as effectively deliver drug that could overcome MDR and enhance
antibiotics efficacy.24

Figure 4: Schematic illustration of study of efflux kinetics of single B.subtilis
transporters in single live cells in real-time using LSPR spectra of single 13.0 ±
3.1 nm AgMUNH-Oflx NPs and AgMUNH2 NPs.24

In Chapter VI, we studied the efflux function of BmrA in both strains of B.subtilis
(WT and ΔBmrA) using 92.6 ± 4.4 nm of AgMUNH-Oflx NPs and AgMUNH2 NPs. We
found that single AgMUNH-Oflx NPs and AgMUNH2 NPs are passively diffused into
cells and are effluxed out bacteria cells as illustrated in Figure 5. We found that
accumulation rates of NPs inside the cells highly depend up on the doses of NPs, types
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of NPs, and expression of BmrA. This study shows that large NPs functionalized with
Oflx can enter the drug and be extruded out by BmrA.25

Figure 5: Schematic illustration of study of efflux kinetics of single B.subtilis
transporters in single live cells in real-time using LSPR spectra of single 92.4 ±
4.4 nm AgMUNH-Oflx NPs.25

Chapter VII, we summarized the research findings described in the previous
chapters, emphasized the importance of the research, and presented possible future
research directions.
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CHAPTER II
STUDY OF EFFLUX FUNCTION OF MULTIDRUG MEMBRANE TRANSPORTERS IN
SINGLE ESCHERICHIA COLI LIVE CELLS USING SINGLE NANOPARTICLE
PLASMONIC SPECTROSCOPY

INTRODUCTION
Multidrug membrane transporters are present in both prokaryotic and eukaryotic
cells,2 in many cases they are responsible for multidrug resistance (MDR). MDR is a key
challenge for treatment of diseases, including cancer and infections.26 MDR involves the
normal efflux out of normal cell substrates, but also can lead to pumping beneficial
drugs out of the cell.5 MDR transporters are classified into two types. One is energy
driven ATP-binding cassette (ABC) transporter, and the other uses proton gradients to
facilitate transport,respectively.26

ATP-binding cassette (ABC) transporters constitute one of the largest and most
diverse membrane protein super-families found in living organisms and they have been
conserved across archaea, eubacteria, and eukarya. 2, 26 ABC transporters use a highaffinity solute binding protein which mediates uptake and export of wide variety of
substrates (ions, sugar, amino acids, proteins, vitamins and drugs) by coupling the
energy released from ATP hydrolysis.1-2,

26-27

ABC transporters in all living organisms

share a familiar constitution, comprising two transmembrane domains (TMDs) and two
cytosolic sites called nucleotide-binding domains (NBDs).2, 26 The TMDs contain several
hydrophobic segments which span the membrane and form transmembrane channels
while NBDs acts as a molecular motor which transforms the chemical potential energy
of ATP into protein conformational changes.2 It is worth noting that the primary
sequences and topology of ABC transporter TMDs are substantially different among
organisms, as compared with NBDs which are composed of conserved Walker A and B
consensus motifs for nucleotide bindings.2 The similar structures and functions of ABC
transporters suggest similarities of efflux function in bacteria and humans. 2 The gram-
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negative bacteria Escherichia coli (E.coli) have an inner membrane, outer membrane
and periplasmic space.28 E.coli is widely used as a model organism to study multidrug
membrane transporters since it has the inner membrane protein MsbA.28 The MsbA
protein is homologous to mammalian multidrug transporter P-glycoproteins (P-gp;
MDR1; or ABCB1) that are remarkably associated with resistance to anticancer drugs in
human raising an essential difficulty in cancer therapies.29

The present techniques for studying of efflux function in bacteria and mammalian
cells including utilizing the measurement of the accumulation of radioactively labeled
substrates (e.g.,

14

C and 3H) and fluorescence dyes (e.g., rhodamine 123, Hoechst dye,

and ethidium bromide).6-9, 30-33 Fluorophores are used to study uptake and efflux kinetics
because the dyes emit weak fluorescence signals in solution (outside cells) and then
become strongly fluorescent in hydrophobic environments especially when they enter
into the cells and intercalate with DNA.6-7 Thus, the accumulation of fluorescence dyes
has been widely used to investigate efflux functions of membrane transporters by
measuring the time-dependent (time-course) fluorescence intensity.6-7 However, these
conventional approaches are unable to probe size-dependent efflux kinetics of
membrane transports of single living cells because individual cells respond differently to
various sizes of substrates.34

Metal nanoparticles (NPs) such as Silver (Ag) and Gold (Au) have unique optical
properties, notably localized surface plasmonic resonance (LSPR) which is the size
dependence of the optical color allowing for size characterization. 32,

35-36

This is an

important phenomenon to ensure nanoparticles are of correct size. Metal nanoparticles
also do not exhibit photo-blinking or photo-decomposition, which is crucial when
monitoring cells for the long duration of time, since the intensity of nanoparticles will be
constant. 36-37

We previously studied Ag NPs with average diameters of 11.8 ± 2.6 nm and 97 ±
13 nm to measure efflux kinetics in a gram-positive bacterium, B.subtilis using Ag NPs
as probes.38-39 We also studied the efflux pump functions in P.aeruginosa (a gram-
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negative bacterium) using Ag NPs of an average diameter of 13.1 ± 2.5 nm and 91.0 ±
9.3 nm. 40

In this study, we synthesized, purified and characterized 12.3 ± 1.8 nm Ag NPs.
LSPR of Ag NPs were used to determine the size of single NPs in real time. This was to
determine if NPs are in the intracellular and extracellular region of MsbA cells. To inhibit
the ABC pump we used orthovanadate,

28-29

an inhibitor for ABC pump in MsbA cells, to

determine whether alternative efflux mechanisms of Ag NPs were present in these cells.
Orthovanadate binds to NBD site and causes a conformation change and closes the
TMD site. 26

RESULTS AND DISCUSSION
Synthesis and Characterization of Stable Ag NPs (12.3 ± 1.8 nm)
We have synthesized Ag NPs as described previously and in Methods.38, 41-42 Ag
NPs were purified by rinsing/washing with nanopure water were centrifuged to remove
any unreacted chemicals and chemical residues. Washing and centrifugation of NPs will
increase the surface charge preventing them from aggregating NPs. The purified NPs in
water are stable for months, as previously reported.40, 43-44 Size and shape of NPs were
determined by high-resolution transmission electron microscopy (HR-TEM) (Fig. 6A)
shows that most of the NPs are spherical in shape. Size distribution as show in Figure
6B was found to be 12.3 ± 1.8 nm, ranging from 8.4 to 19.0 nm. Dark-field optical
images as shown in Figure 6C; the majority of them are blue, green, and few are red
NPs. Their LSPRs are shown in Figure 6D: blue color NP having peak wavelength
(λmax) with full-width half maximum (FWHM) at 469 (83.1) nm, green λmax 540 (101.3)
nm, and red λmax at 605 (106.5) nm.
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Figure 6: Characterization of the size, shape, and concentration of Ag NPs in
Nanopure water.

(A) HR-TEM images of Ag NPs show a spherical shape and average size distribution of
12.3 ± 1.8 nm. (B) Histogram of size distribution of Ag NPs shows the average size of
nanoparticles to be 12.3 ± 1.8 nm. (C) DFOM image of single Ag NPs in water showed
majority blue. (D) LSPR spectra of single NPs as squared in (C) Blue, green and red
with λmax at (i) 469 nm (ii) 540 nm (iii) 605 nm respectively (E) The color distribution of
Ag NPs in water are (72 ± 2) % blue, (22 ± 2) % green and (6 ± 1) % red NPs. (F)
Representative UV-vis absorbance spectra of 1.4 nM Ag NPs well dispersed in water
peak wavelength is 393 nm and FWHM is 64.3 nm. Scale bars are 10 nm in (A) and 2
µm in (C) (Scale bar in (C) shows the distance between single NPs, but not their sizes.
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Figure 7: Characterization of optical properties and stability of Ag NPs in PBS.
(A) Representative UV-vis absorbance spectra of 12.3 ± 1.8 nm Ag NPs well dispersed
in medium at (a) 0 h and (b) 12 h. (B) The size distribution of Ag NPs of a 1.4 nM Ag
NPs solution in PBS buffer as determined by DLS remained nearly a constant with an
average value of (12.33 ± 2) nm. (C) The total number of nanoparticles/image of a 1.4
nM Ag NPs solution in PBS buffer remained nearly a constant for the duration of the
experiment (12 h) with an average value of ( 243 ± 5) NPs/20images.
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To study the efflux function and accumulation rates, bacteria were suspended in
phosphate buffer saline (PBS) buffer instead of the medium since bacteria cells will
continue to grow in the medium.

6-7, 9, 30, 45

It is important to study the stability (non-

aggregated) of NPs in PBS buffer over the duration of the experiments. We studied the
viability of MsbA in PBS buffer: bacteria cells were viable for at least 8 h at room
temperature (data not shown). Figure 7A shows UV-vis spectra of Ag NPs solution at
time zero and at 12 h of the experiment. The peak wavelength remained unchanged
over time, indicating that the sizes and shapes of NPs remain unchanged; however, the
absorbance is slightly decreased due to adsorption of PBS buffer on the NPs. The size
distributions of NPs were then characterized by dynamic light scattering (DLS) which
shows average diameter of NPs as shown in Figure 7B. The size of NPs was larger at
12 h; this may be attributed to solvation of NPs with the buffer. The diameter of NPs
measured from HRTEM (dry vacuum) and DLS are different due to the different way of
calculation of NPs. We further confirmed the stability of single NPs under dark-field
optical microscopy and spectroscopy (DFOMS) (Fig. 7C), the average number of NPs
per 20 images was 243 ± 5. If there were aggregation of NPs, we would have seen
fewer NPs as time proceed. From Figure 7 we can conclude Ag NPs are stable in buffer
solution for at least 12 h.

The representative dark-field optical images of the MsbA cells with single
intracellular and extracellular NPs are shown in Figure 8A. Figure 8B consists of
magnified images of intracellular NPs within the cells. Scattering Intensity of NP inside
cells were low since the dark-field microscopy illuminator needs to pass through the cell
membrane and reach detector hence, NPs look dimmer inside whereas extracellular
has higher intensity and looks brighter as shown in Figure 8C. This distinguishing
feature of the NPs enables us to determine the intracellular or extracellular location.
LSPR of NPs was acquired to distinguish NPs and cell debris. Cell debris will not have
LSPR, hence they look white. The representative LSPR spectra (color) of single Ag NP
in Figure 8D show individual NPs with peak wavelengths (λmax) at 530 (blue), 550
(green) and 555 (green) nm, respectively.
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Concentration-Dependent and accumulation rate of Single NPs in Single Live
Cells
We want to know whether MsbA with single NPs have the same attributes of
pump substrates (eg, antibiotics) and exhibit concentration-dependence. 1.4 nM Ag
NPs, at 10.5, 30.5, and 50.5 min, the accumulation of intracellular NPs was 16.7, 16.5
and 14.0 intracellular NPs/min for 300 cells, respectively (Fig. 9Ab). For cells incubated
with 0.7 nM Ag NPs, the accumulation of intracellular NPs was 10.9, 9.7, and 6.4
NPs/min at 10.5, 30.5, and 50.5 min (Fig. 9Bb). From (Fig. 9Ab-9Bb), the number of
intracellular NPs depends on NP concentration. When concentration of NPs is
increased from 0.7 nM to 1.4 nM which is 2x increases in concentration we saw 2x
increase in accumulation rate. From these results, we can conclude that cells incubated
with Ag NPs extrude the NPs in a concentration-dependent manner.
Next, we used orthovanadate an inhibitor of MsbA pump since we do not have a
genetic mutant and we inhibited its function with orthovanadate. After cells were
incubated with 1.4 nM Ag NPs and orthovanadate, at the beginning i.e., 10.5 min, the
accumulation of intracellular NPs was 13.4 intracellular NPs/min for 300 cells. When we
compared with 1.4 nm Ag NPs we found similar accumulation rates of intracellular NPs
due to orthovanadate onset time to show its actions. In contrast, the accumulation of
intracellular NPs was 32.4 and 53.9 intracellular NPs/ min at 30.5 and 50.5 min (Fig.
9Aa), which was an increase in accumulation of NPs. The accumulation rate (slope of
the plot) of 1.4 nM Ag NPs with orthovanadate is 1.08 NPs/min at 30.5, whereas for 1.4
nM Ag NPs alone is 0.65, which was 1.7 times more than Ag NPs. The quantitative
intracellular NPs accumulated and the accumulation rate in single live cells at a given
times are summarized in Table 1. As previously mentioned, we also studied the 0.7 nM
Ag NPs where the number of intracellular NPs 10.9 , 9.7 and 6.4 min at 10.5, 30.5 and
at 50.5 min (Fig. 9Bb), whereas cells incubated with orthovanadate and 0.7 nM Ag NPs
showed 8.9, 10.4 and 22.6 at 10.5 , 30.5 and 50.5 min (Fig. 9Ba).
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Figure 8: Imaging of single intracellular and extracellular 12.3 ± 1.8 nm Ag NPs in
single living bacterial cells using DFOMS.
(A) The representative optical image of bacterial cells incubated with 1.4 nM Ag NPs
showing extracellular NPs as squared. (B, C) Zoom in optical color images of single
cells shows (B) intracellular and (C) extracellular NPs. The scale bar in A and B are 5
and 2 µm, respectively. (D) LSPR spectra of Single 12.3 ± 1.8 nm Ag NPs show peak
wavelength at 530 nm, 550 and 555 nm.
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Figure 9: Study of efflux kinetics of MsbA membrane transporter using 12.3 ± 1.8
nm Ag NPs.

(A) Plots of number of intracellular Ag NPs in MsbA incubated with (a) 1.4 nM Ag NPs
with Orthovanadate and (b) 1.4 nM Ag NPs (B) Plots of number of intracellular Ag NPs
in MsbA incubated with (a) 0.7 nM Ag NPs with Orthovanadate and (b) 0.7 nM Ag NPs.
(C) Plots of fluorescence intensity of EtBr dye at (a) 15.0 µM with Orthovanadate (b)
and 15.0 µM versus time.
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We further studied the time course of fluorescence intensity of 15 µM ethidium
bromide (EtBr) in the cell solution with and without orthovanadate in order to study the
accumulation rate. More EtBr is accumulated in cells with orthovanadate (Fig. 9Ca) until
60 min; after that, the accumulated rate decreased whereas EtBr and cells remained
almost same (Fig. 9Cb). From Figure 9Aa, 9Bb and 9Ca after 60 min orthovanadate did
not work which indicated that cells used all orthovanadate available in the solution.

Table 1: Study of Accumulation Rates and Number of Intracellular Single 12.0 nm NPs
in Single Live Cells
Diameter
(nm) a
12.3 ± 1.8

C Ag NPs
(nM)
1.4 nM + orthovanadate
1.4 nM
0.7 nM + orthovanadate
0.7 nM

Accumulation
Rate (NPs min-1)b
1.08
0.65
0.39
0.39

Number of
Intracellular NPsc
46
33
19
21

a

Diameter of NPs measured by TEM;

b

Accumulation rates (slopes of plots) of the NPs in 300 live cells over 30.5 min (Figure

9 );
c

Number of intracellular NPs accumulated in 300 live cells at 30.5 min incubation;

From these results, we can conclude that cells incubated with Ag NPs extrude the NPs,
whereas cell incubated with orthovanadate and Ag NPs do not extrude the

NPs,

causing more persistent accumulation of NPs. In this study the size of NPs were much
smaller than regular antibiotics which are effluxed out from MsbA pump. NPs cannot be
engulfed (pinocytosis, endocytosis, and exocytosis) inside the bacteria cells because
they do not have this capability.
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Viability of Single Cells
The viability of single cells with NPs is a key step in the study of accumulation of
intracellular NPs since NPs easily enter into dead cells. The cells and NPs incubated
with and without orthovanadate were characterized by live/dead BacLight viability and
counting assay.46 This assay used SYTO9, a green fluorescent nucleic acid stain and
propidium iodine, a red fluorescence nucleic acid stain to distinguish live and dead cells
respectively. SYTO9 labels those bacteria with the intact or live cells but not dead cells
whereas propidium iodine penetrates only into damaged cell membranes leading to a
reduction of SYTO9 fluorescence intensity. Bacteria with intact cell membrane (alive
cells) penetrate SYTO9 and appear to the green fluorescence (λmax at 520 nm) whereas
damaged (dead cells) penetrate propidium iodine and appear to the red fluorescence
(λmax at 610 nm), which enabled us to distinguish between live and dead cells.
Representative optical images of the MsbA cells incubated with 1.4 nM Ag NPs
with orthovanadate (Fig. 10A) for a 2 h showed the cells with and without NPs; their
fluorescent images are green (Fig. 10B), but not red fluorescent. We can conclude that
cells are alive with and without NPs. We calculated the number of live cells and dead
cells and showed the percentage of the cells by dividing the number of live cells over
the total number of cells. The results showed that 98 % (Fig. 10Ca) and 95 % (Fig.
10Cb) were live for at least 2 h when incubated with 1.4 nM Ag NPs with and without
orthovanadate respectively. Cells incubated with 0.7 nm Ag NPs with and without
orthovanadate were live with 99 % (Fig. 10Cc) and 95 % live (Fig. 10Cd), respectively.
This result shows that the accumulation of NPs is not by cell membrane damage.

SUMMARY
In summary, we have successfully synthesized 12.3 ± 1.8 nm Ag NPs. We used
localized surface plasma resonance of Ag NPs to determine the size and also to
determine whether NPs are localized intracellular or extracellular with respect to the
bacterial cell membrane. 1.4 nM Ag NPs are stable in PBS buffer for at least 12 h. We
observed a concentration-dependent efflux function when incubated with 1.4 nM and
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A

B
B

Figure 10: Characterization of the viability of single bacterial cells using live/dead
Baclight viability and counting assay.
Representative dark-field optical image (A) and fluorescence image (B) of single
bacterial cells (MsbA), incubated with 1.4 nM Ag NPs with Orthovanadate over the
duration of each experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of
SYTO9, indicating that cells are viable. (C) Plots of percentage of viable cells (a) 1.4 nM
Ag NPs and orthovanadate (b) 1.4 nM Ag NPs cells (C) 0.7 nM Ag NPs and
orthovanadate (d) 0.7 nM Ag NPs of MsbA, indicate that 95-99% of the cells are alive.
Minimum 300 cells were assayed and analyzed. The scale bar is 2 µm.
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0.7 nM Ag NPs. We incubated cells with Ag NPs and orthovanadate, an inhibitor of ABC
transporters, after the onset of time of orthovanadate; we saw more of intracellular NPs.
Accumulation rate was 1.7 times more when incubated with orthovanadate. Inhibition of
pump with orthovanadate causes accumulation of a higher number of intracellular NPs.
More than 95% of cells are viable for 2 h incubated with Ag NPs which indicating that
NPs are biocompatible and can be used to study efflux functions. From this study, we
can conclude that Ag NPs can be used as probes that enter into the cell passively and
efflux out through ABC transporter.

METHODS
Reagents and cell line
Silver perchlorate monohydrate (99%) was purchased from Alfa Aesar. Sodium
citrate (99%), sodium borohydride (NaBH4) (98%), sodium orthovanadate (99%)
Ethidium bromide, sodium chloride, sodium phosphate, sodium phosphate monobasic
monohydrate, bacto-tryptone and bacto yeast extract were purchased from SigmaAldrich. Live/dead BacLight viability and counting assay was purchased from Invitrogen.
All reagents were used as received. The nanopure deionized (DI) water (18 MΩ water,
Barnstead) was used to prepare all solutions including 50 mM phosphate buffer saline
(PBS) (pH=7.2, 0.5 mM phosphate buffer and 1.5 mM sodium chloride) and rinse
glassware. MsbA (Escherichia coli, wt w3110) cells were purchased from purchased
from Coli Genetic Stock Center (CGSC).

Synthesis and characterization of Ag NP optical probes
Ag NPs (12.3 ± 1.8 nm) were synthesized and purified as described previously. 38,
41, 47

Sodium borohydride (10 mM) solution was mixed with ice-cold sodium citrate (3

mM). Silver perchlorate (10 mM, ice-cold) was rapidly added to the mixture and the
solution was homogeneously stirring at room temperature overnight. The solution was
filtered through 0.22 µm membrane and washed twice with nanopure water using
centrifugation (Beckman Optima L90k) at 15,000 rcf (relative centrifugal force). The
purified Ag NPs were resuspended in nanopure water and stored in dark at 4°C. The
molar concentration of Ag NPs was determined and calculated using UV-vis
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spectroscopy (Hitachi U-2010) as described previously. The washed Ag NPs were
determined their sizes using high-resolution transmission electron microscopy (HRTEM,
FEI Tecnai G2 F30 FEG) and dynamic light scattering (DLS, Nicomp 380ZLS particle
size system). Optical properties of NPs were characterized using dark-field optical
microscopy and spectroscopy (DFOMS).Our setup for DFOMS is explained in our
previous studies.32,

35-38, 40, 42-44, 48-49

Our DFOMS is equipped with a dark-field optical

microscope, which includes a dark-field condenser (oil 1.43–1.20, Nikon) and a 100×
objective (Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth
of field (focus) of 190 nm, a charge coupled device (CCD) camera (Micromax, Roper
Scientific) and Multispectral Imaging System (Nuance, CRI). 37 ,50

The purified Ag NPs suspended in nanopure water and 0.5 mM PBS was
characterized over 12 h to investigate their stability (non-aggregated) using UV-vis
spectroscopy and dynamic light scattering. Ag NPs dispersed in 0.5 mM were sampled
to take dark-field optical images (initial, 4h, 8h and 12h). The experiment was done in
triplicate and total number of NPs of each run was counted at all-time points.

Cell culture and preparation
We pre-cultured the cells in an Erlenmeyer flask (250 mL) containing 20 mL of
luria broth (LB) medium (1% tryptone peptone, 0.5% yeast extract and 0.5% sodium
chloride, pH = 7.2) in a shaker (Lab-line Orbit Envivon-Shaker) (150 rpm, 37°C) for 12h.
The cells were further cultured in the LB medium for another 8 h. We harvested the
cultured cells using centrifugation (Beckman Model J2-21 Centrifuge, JA-14 rotor) at
1500 rpm for 10 min. The cells were washed with the PBS three times and resuspended
in the PBS. The final concentration of the cells was adjusted to OD 600nm = 0.1 and used
for the entire experiments.

Imaging of single intracellular and extracellular Ag NPs in single living cells
The cell suspensions (1 mL) containing 0.7 nM and 1.4 nM of Ag NPs in the
presence and absence of orthovanadate (25 µM) were prepared. The incubation time
was started after adding Ag NPs to the cell suspension. The suspension was sampled
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(1 µL) in every 20 min and prepared the micro-chamber slide. The cells were imaged at
representative locations in every minute using DFOMS equipped with a CCD camera.

At the end of each experiment, the viable cells were characterized using
live/dead BacLight bacterial viability and counting assay. 46 The cells were imaged darkfield optical microscopy and epi-fluorescence microscopy for at least 300 cells. The
green fluorescent cells (peak wavelength of fluorescence spectra of SYTO9, λmax = 520
nm) were counted as viable cells and the red fluorescent cells (peak wavelength of
fluorescence spectra of propidium iodide, λmax = 610 nm) were counted as dead cells.
Fluorescence spectroscopy measurements
Time-dependent of fluorescence intensity of 15 µM ethidium bromide incubated
with the 3 mL cells in the presence and the absence of orthovanadate was measured in
a 3 s interval using a fluorescence spectrometer (Perkin-Elmer LS50B). The excitation
and emission wavelengths were 488 and 590 nm, respectively.

Data analysis and statistics
For characterization of NPs size and color distribution, we measured at least 100
NPs by using HR-TEM and DFOMS for each measurement and each measurement
was repeated three times. Therefore, a minimal of 300 NPs was characterized giving
sufficient statistics for determination of size distribution.

We acquired 20 representative images of each cell suspensions incubated with
1.4 nM, 0.7 nM Ag NPs with and without orthovanadate for every 20 min over a period
of 2 h to study accumulation rate of intracellular NPs in single cells. Therefore nearly
~100 cells were imaged every 20 min, and 600 cells were studied over 2 h for each
measurement. Each experiment was repeated three times. Thus, 1800 cells were
studied for each sample, which allowed us to gain sufficient statistics for probing
accumulation rates and efflux kinetics of bulk cells at single cell resolution.
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CHAPTER III
STUDY OF SIZE-DEPENDENCE OF INHIBITORY EFFECTS OF DRUG NANOCARRIERS IN BACILLUS SUBTILIS

INTRODUCTION:
Multidrug resistance (MDR) is the leading cause of failure when treating cancers
and bacterial infections.5 Bacteria acquire resistance to drugs by changes in the activity
of MDR transporters, which extrude drugs or other substances outside the cells. 5 Two
types of MDR transporters are present, proton gradient and adenosine triphosphate
(ATP) binding cassette (ABC) transporter which use the energy of ATP hydrolysis to
establish the gradient.1 ABC transporters are involved in the transport of a variety of
structurally dissimilar compounds and contain two transmembrane domains (TMDs) and
two nucleotide-binding domains (NMDs).1,

3-5

Studies have shown that the substrates

bind to TMDs and form a way for substrates to cross the membranes, whereas NBDs
bind and hydrolyze ATP to power the transporters, which causes the extrusion of
substrates out of cells against the concentration gradient across the cellular
membranes.1, 4-5

Fluoroquinolones such as benofloxacin, danofloxacin, enrofloxacin, norfloxacin,
and ofloxacin are widely used broad spectrum antibiotics51 used for the treatment of
bacterial diseases such as pneumonia, chronic bronchitis, urinary tract infections and
tuberculosis.52 To study antibiotic resistance levels in bacteria many qualitative and
quantitative methods have been developed.53 Broth dilution and an agar plate technique
are the most common method to study susceptibility of bacteria and determine the
minimum inhibitory concentration (MIC) of antibiotics. 53
Nanoparticles have gained much attention due to their wide applications.54-58
Noble metal nanoparticles such as Gold (Au) and Silver (Ag) have distinctive optical
properties, depending on size, charge, and the surrounding environment.

54-58

Ag NPs

have high Rayleigh scattering and can be imaged under dark-field optical microscopy
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using halogen as a source of illumination.32,

35, 37, 39-40, 43-44, 49-50, 59

The scattering

intensity of nanoparticles is constant for long durations of time (eg, hours), which is
crucial for monitoring cells over time. Additionally nanoparticles do not exhibit photoblinking or photo-decomposition.

32, 35, 37, 39-40, 43-44, 49-50, 59

Nanoparticle surfaces are

functionalized with a receptor or mono-clonal antibody to identify a certain type of cells
and are functionalized with drugs for drug delivery.59 Our group has developed a wide
range of colors of single-molecule nanoparticle optical probes and biosensors
(SMNOBS) that are utilized for the imaging and characterization of molecular
mechanisms in single live cells.

In our previous studies, we used aztreonam (AZT) which inhibits bacterial growth
by destroying cell wall synthesis and we used chloramphenicol (antibiotic) to study
efflux function in P.aeruginosa.34,

36

The size-dependent inhibitory effect of antibiotic

drug nano-carriers in P.aeruginosa was also studied.60 In this study, we used three
different sized drug nano-carriers and studied minimum inhibitory concentrations in
B.subtilis. B.subtilis is a gram-positive bacteria which served as our model organism
while studying efflux function of multidrug ABC membrane transporter. In addition, 78
ABC transporters have been identified in B.subtilis species making it ideal for our
studies.61-63

RESULTS AND DISCUSSION:
Synthesis and Characterization of Drug Nano-carriers
We synthesized 2.4 ± 0.7 nm Ag NPs, 13.0 ± 3.1 nm Ag NPs, and 92.6 ± 4.4 nm
Ag NPs as described in the earlier paper and in methods. 35,

37, 40

Figure 11 shows

representative images of TEM. Size distribution of the NPs were shown to be 2.4 ± 0.7
nm, 13.0 ± 3.1 nm, and 92.6 ± 4.4 nm Ag NPs as described in the paper.60 Once NPs
were synthesized and purified, NPs surface was functionalized with a monolayer of 11amino-1-undecanethiol hydrochloride (MUNH2). Once the reaction was completed we
washed them and characterized AgMUNH2 NPs. The amine group of AgMUNH2 NPs
was linked with Ofloxacin (Oflx) via a peptide bond with the carboxyl group of Oflx and
amine group of MUNH2. Figure 12A schematic synthesis of 2.4 ± 0.7 nm AgMUNH-Oflx
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A

B

C

Figure 11: Characterization of three different size Ag NPs using HRTEM.

(A) Size characterization of 2.4 ± 0.7 nm Ag NPs. HRTEM image shows nearly uniform
spherical nanoparticles. The scale bar is 5 nm. (B) Size characterization of 13.0 ± 3.1
nm Ag NPs. HRTEM image shows nearly uniform spherical nanoparticles. The scale
bar is 10 nm.(C) Size characterization of 92.6 ± 4.4 nm Ag NPs HRTEM image shows
nearly uniform spherical nanoparticles. The scale bar is 100 nm.
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Figure 12: Illustration of synthesis of drug nano-carriers.

Schematic illustration of functionalization of monolayer of 11-amino-1-undecanethiol on
the surface of the NPs with diameters of (A) 2.4 ± 0.7, (B) 13.0 ± 3.1 and (C) 92.6 ± 4.4
nm using the interaction of their thiol groups (-SH) with the surface of Ag NPs to prepare
AgMUNH2 NPs and conjugation of the amine group of 11-amino-1-undecanethiol with
the carboxyl group of the Oflx via peptide bonds using EDC and sulfo-NHS as
mediators to prepare AgMUNH-Oflx NPs.
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(drug nano-carriers), Figure 12B schematic synthesis of 13.0 ± 3.1 nm AgMUNH-Oflx
NPs (drug nano-carriers) and Figure 12C schematic of the synthesis of 92.6 ± 4.4 nm
AgMUNH-Oflx NPs (drug nano-carriers).

Dark-field optical images of 2.4 ± 0.7 nm Ag NPs (Fig. 13Aa), AgMUNH2 (Fig.
13Ab), and AgMUNH-Oflx NPs (Fig. 13Ac) showed majority blue color NPs in Ag NPs,
green color in AgMUNH2 and green color in AgMUNH-Oflx NPs. LSPR Figure 13Ad of
Ag NPs, NPs functionalized with MUNH2 and Oflx, NPs shift from blue to green and
peak wavelength (λmax) 482, 534, and 555 nm. Dark-field optical images of 13.0 ± 3.1
nm Ag NPs (Fig. 13Ba), AgMUNH2 (Fig. 13Bb), and AgMUNH-Oflx NPs (Fig. 13Bc),
showed majority blue, green and few red color NPs in Ag NPs, green color in AgMUNH 2
and green color in AgMUNH-Oflx NPs. LSPR (Fig. 13Bd) of Ag NPs, NPs functionalized
with MUNH2 and Oflx, peak wavelength (λmax) of NPs are 521, 535, and 554 nm. Darkfield optical images of 92.6 ± 4.4 nm Ag NPs (Fig. 13Ca), AgMUNH2 (Fig. 13Cb), and
AgMUNH-Oflx NPs (Fig. 13Cc) showed majority green and few red color NPs in Ag
NPs, green color in AgMUNH2 and green color in AgMUNH-Oflx NPs. LSPR of Ag NPs
are functionalized with MUNH2 and Oflx, peak wavelength (λmax) of NPs are 533, 560,
and 580 nm. The shift of NPs is due to decrease of the surface refractivity and dielectric
constant as well as increasing in sizes.

We studied the stability of antibiotic drug nano-carriers in the medium as shown
in the previous paper.60 We determined the conjugation ratio (the number of Oflx
molecules attached to a single NP) of 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm as
8.6x102, 9.4x103, and 6.5x105 respectively.
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Figure 13: Characterization of plasmonic optical properties of single (a) Ag NPs,
(b) AgMUNH2 NPs, (c) AgMUNH-Oflx NPs and (d) LSPR of individual NPs.
(A) Dark-field optical image of single 2.4 ± 0.7 nm Ag NPs (i) blue color Ag NPs, (ii)
green color AgMUNH2 NPs (iii) green color AgMUNH-Oflx NPs (d) Normalized
scattering intensity of single NPs in (A) shows with peak wavelength (λmax) and fullwidth-half maximum (FWHM) at (i) 482 (50) (ii) 534 (113) and (iii) 555 (120) nm. (B)
Dark-field optical image of single 13.0 ± 3.1 nm Ag NPs, (i) green color Ag NPs (ii)
green color AgMUNH2 NPs (iii) green color AgMUNH-Oflx NPs (d) Normalized
scattering intensity of NPs in (B) shows with λmax (FWHM) at (i) 521 (47) and (ii) 535 (67)
and (iii) 554 (81) nm. (C) Dark-field optical image of single 92.6 ± 4.4 nm Ag NPs (i)
green color Ag NPs, (ii) green color AgMUNH2 NPs and (iii) green color AgMUNH-Oflx
NPs (d) Normalized scattering intensity of NPs in (C) shows with λmax (FWHM) at (i) 533
(99) (ii) 560 (121) and (iii) 580 (147) nm. The scale bars are 10 µm showing distance
among individual NPs but not their sizes due to the optical diffraction limit.
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Cell function in modified medium
Since antibiotic drug nano-carriers are aggregated in the standard medium, the
medium was modified medium in such a way that the drug nano-carriers were stable in
medium (we call this modified medium). It is very important to make sure cell function is
the same in modified medium hence we studied the growth curve and efflux functions of
B.subtilis cells in modified medium and regular medium. We followed the growth curve
of two strains of B.subtilis: WT normal expression of BmrA (Bacillus multidrug
resistance ATP) and ΔBmrA deleted BmrA pump in standard and modified medium.
Results, as shown in Figure 14Aa (standard medium) and Figure 14Ab (modified
medium) of WT demonstrate that the growth curves are almost the same. The same
phenomenon was seen for ΔBmrA in Figure 14Ba and Figure14Bb in regular and
modified medium respectively. At the end of the growth period, i.e. 18 h, cell viability
was measured by using live/dead BacLight assay. Live/dead BacLight assay contain
two fluorescent dyes: green fluorescent dye SYTO9 (λmax = 520 nm) which binds nucleic
acids which stains only live cells thus live cells appear green fluorescent and a red
fluorescent dye propidium iodide (λmax = 610 nm) which penetrates into damaged or
disintegrated cells showing in red fluorescence.46 Figure 15 shows representative
optical images (Fig. 15A) and green fluorescence (Fig. 15B) of WT in Figure 15Aa,
Figure 15Ab cells in standard medium and modified medium respectively. We counted
the number of live and dead cells and calculated the percentage of viable cells by
dividing the number of live cells over the total number of the cells. The results show that
97-100% of the cells are viable for both strains and in both mediums (Fig. 15C). From
these results, we can conclude that cells are growing normally in modified medium also.
We next studied the effluxed mechanism using Hoechst dyes. Cells were incubated with
2 µM Hoechst dye and we studied the time course of fluorescence intensity for the
duration of 40 mins for both the strains, in both the standard medium and modified
medium. Figure 16A is the time course of fluorescence intensity in the standard
medium, whereas Figure 16B is in the modified medium time course. From 0-15 mins, a
higher amount of Hoechst dye accumulated in ΔBmrA (Fig. 16Ab). After 15 mins, cells
reached saturation and remained constant for 40 mins, whereas in WT (Fig. 16Ca) it
remained constant over time.
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Figure 14: Characterization of growth curves of the cells cultured in (a) standard
and (b) modified LB medium.
The cellular growth curves of: (A) WT, (B) ΔBmrA cultured in (a) standard and (b)
modified LB medium over time shows that the growth rates of a given strain in either
medium are nearly identical, which indicates that the modified LB medium is well suited
to culture the cells.
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Figure 15: Viability of the cells (WT, ΔBmrA) cultured in (a) standard and (b)
modified LB medium using Live/Dead BacLight assay.

(A) Optical and (B) fluorescence images of the cells (e.g., WT), that were cultured over
12 h, and suspended in the PBS buffer and assayed using Live/Dead BacLight assay.
The cells exhibiting green fluorescence and red fluorescence are counted as live and
dead cells, respectively. (C) Plot of the percent of the live cells (live cells divided by the
total number of given cells) cultured in (a) standard and (b) modified LB medium show
that more than 97% of the cells (WT, ΔBmrA) are viable, which further indicates that the
modified LB medium is well suitable to culture the cells. The scale bars in (A-B) are 5
µm.
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Figure 16: Characterization of accumulation and efflux kinetics of the Hoechst
dye for live cells cultured in (A) standard and (B) modified LB medium.

Time-dependent fluorescence intensity of Hoechst (2 µM) incubated with the cells
(OD600 nm = 0.1 in PBS buffer, pH 7.2): (a) WT and (b) ΔBmrA cultured in (A) standard
and (B) modified LB medium exhibit almost same accumulation and efflux kinetics,
demonstrates that the modified LB medium is well suitable to culture the cells for the
study of accumulation and efflux kinetics of B.subtilis
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Even 16B showed the same phenomena indicating that cells are effluxing
Hoechst dye as usual in the modified medium as well. From this we can conclude that
cell function is the same in modified medium.

Study of size-dependent biocompatibility and toxicity of the drug nano-carriers
We incubated B.subtilis (WT and ΔBmrA) with different concentration of 2.4 ± 0.7
nm AgMUNH-Oflx, 13.0 ± 3.1 nm AgMUNH-Oflx, 92.6 ± 4.4 nm AgMUNH-Oflx, and Oflx
alone. For controls NPs, the highest concentration of 2.4 ± 0.7 nm AgMUNH2, 13.0 ± 3.1
nm AgMUNH2, and 92.6 ± 4.4 nm AgMUNH2 were used. Figure 17 shows test tubes
images taken at 18 h of incubation with samples. Figure 17A, 17C, 17E, and 17D are
WT cells and Figure 17B, 17D, 17F, and 17H are ΔBmrA cells. Figure 17A and 17B
were 2.4 ± 0.7 nm drug nano-carriers, Figure 17C and 17D were 13.0 ± 3.1 nm drug
nano-carriers, and Figure 17E and 17F was 92.6 ± 4.4 nm drug nano-carriers with
different concentration of Oflx. The concentration of drug nano-carriers is converted to
Oflx concentrations based on the conjugation ratio, 0.06, 0.11, 0.22, 0.42, and 0.72 µM
from a-e, whereas f was 0.72 µM of 2.4 nm AgMUNH2, as concentration of Oflx
increased, the bacteria growth decreased whereas samples contain AgMUNH 2 with the
highest concentration (0.72 µM) did not inhibit growth of bacteria indicating that
AgMUNH2 is biocompatible to cells. Figure 17G, 17H is Oflx alone as the concentration
of oflx increased from 0.00, 0.06, 0.11, 0.22, 0.42, and 0.72 µM from a-f bacterial growth
was inhibited.

Beyond qualitatively looking visually or at the turbidity of the test tube, we further
quantified the growth by measuring the absorbance (optical density) at 600 nm
(OD600nm) which is one standard method used to measure bacteria growth. We plotted a
graph of OD600nm versus concentration in µM as shown in Figure 18A as WT Figure 18B
as ΔBmrA a, b, c is 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm AgMUNH2 NPs d, e, f, g are
2.4 ± 0.7 nm AgMUNH-Oflx, Oflx, 13.0 ± 3.1 AgMUNH-Oflx, and 92.6 ± 4.4 nm
AgMUNH-Oflx.
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Figure 17: Determination of minimum inhibitory concentrations (MIC) of
AgMUNH2-Oflx NPs and ofloxacin in B.subtilis.
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Figure 17 cont.: A, C, E and G in WT B.subtilis (WT) while B, D, F and H in Δ B.subtilis
( ΔBmrA) at 18 h. (A, B) Images of test tubes of cells containing conjugated ofloxacin in
2.4 ± 0.7 nm AgMUNH-Oflx at (a) 0.06, (b) 0.11, (c) 0.22, (d) 0.42, and (e) 0.72 µM.
Cells also were incubated with AgMUNH2 NPs (drug free) at 0.72 µM (f). (C, D)Images
of test tubes of cells containing conjugated Ofloxacin in 13.0 ± 3.1 nm AgMUNH-Oflx at
(a) 0.06, (b) 0.11, (c) 0.22, (d) 0.42, and (e) 0.72 µM. Cells also were incubated with
AgMUNH2 NPs (drug free) at 0.72 µM (f). (E, F) Images of test tubes of cells containing
conjugated ofloxacin in 92.6 ± 4.4 nm AgMUNH-Oflx at (a) 0.06, (b) 0.11, (c) 0.22, (d)
0.42, and (e) 0.72 µM. Cells also were incubated with AgMUNH2 NPs (drug free) at 0.72
µM (f). (G, H). Images of test tubes of cells containing Oflx at (a) 0.0, (b) 0.06, (c) 0.11,
(d) 0.22, (e) 0.42, and (f) 0.72 µM after 18 h incubation.

From Figure 18, as the concentration of Oflx increased the absorbance
decreased indicating that bacteria growth is dependent on concentration of Oflx. The
order of the growth curve was 2.4 ± 0.7 nm AgMUNH-Oflx NPs growth was more than
Oflx alone. Next was 13.0 ± 3.1 nm AgMUNH-Oflx NPs and was 92.6 ± 4.4 nm
AgMUNH-Oflx NPs. AgMUNH2 NPs are almost same as 0.0 µM of Oflx indicating that
AgMUNH2 is biocompatible. We calculated 50% of the minimum inhibitory concentration
using an exponential decay curve fitting y=a*exp(b*x),64 found MIC50 values (Table 2)
were 0.401 ± 0.021, 0.162 ± 0.002, 0.118 ± 0.006, and 0.013 ± 0.006 µM for WT
whereas for ΔBmrA 0.490 ± 0.027, 0.174 ± 0.017, 0.111 ± 0.011, and 0.013 ± 0.001 µM
for 2.4 ± 0.7 nm AgMUNH-Oflx, Oflx alone, 13.0 ± 3.1 nm AgMUNH-Oflx, and 92.6 ±
4.4nm AgMUNH-Oflx respectively. We saw a size dependent inhibitory effect in both
strains. No strain dependency was observed, possibly because the concentration was
too high or low, or cells had already acquired resistance.
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Figure 18: Plot of absorbance (y) versus the concentration, MIC50 is calculated
from using exponential decay with y=a exp(-bx) equation at 18 h.
A and B MIC of Oflx in WT and ΔBmrA using UV-vis spectroscopy. (a) 2.4 ± 0.7 nm
AgMUNH2 (b) 13.0 ± 3.1 nm AgMUNH2 (c) 92.6 ± 4.4 nm AgMUNH2 (d) 2.4 ± 0.7 nm
AgMUNH-Oflx y

WT=

0.170e(-1.961c) ,R2 = 0.841 ; y

ΔBmrA

= 0.189e(-1.586 c), R2 = 0.711, (e)

Oflx alone y WT =0.174e(-4.996c), R2 = 0.918 ; y ΔBmrA = 0.193e(-4.542c), R2 = 0.924 ,(f) 13.0 ±
3.1 nm AgMUNH-Oflx y

WT

=0.169e(-6.591c), R2 = 0.886 ; y

ΔBmrA

= 0.183e(-7.025c), R2 =

0.907 and (g) 92.6 ± 4.4 nm AgMUNH-Oflx y ΔBmrA = 0.155e(-53.330c), R2 = 1.00 ; y ΔBmrA =
0.172e(-52.860 c), R2 = 1.00.

37
UV-vis absorbance is a bulk phenomenon and from the absorbance data, it is
unknown how the morphology of the bacterium changed due to the inhibitory effects of
Oflx. The inhibitory effect is due to the accumulation of NPs. To circumvent these
limitations, we used DFOMS images to observe the bacterial morphology as well as to
count the number of bacteria for each concentration. As shown in Figure 19, there are
dark-field images of a bacteria cell with drug nano-carriers. We saw few NPs attached
to cells. Figure 19a, 19b, 19c, and 19d are 2.4 ± 0.7 nm, 13.0 ± 3.1 nm , 92.6 ± 4.4 nm
AgMUNH-Oflx NPs and cells alone respectively. In the cells in Figure 19a, 19b, and 19c
some cells have not divided properly indicating Oflx inhibited cell division; the
mechanism action of Oflx is by DNA gyrase and DNA gyrase is required to complete
replication prior to cell division.51

Table 2: Summary of Minimum Inhibitory Concentration AgMUNH2-Oflx for B.subtilis

NPs
2 nm AgMUNH-Oflx
13 nm AgMUNH-Oflx
92 nm AgMUNH-Oflx
Ofloxacin

Ag NPs
Diameter
(nm)
2.4 ±0.7
13.0 ±3.1
92.6 ±4.4
n/a

* MIC calculated at 50% at T 18 h.
MIC is calculated from y= a exp(-bx)

WT
UV-vis
0.401
0.118
0.013
0.162

Single
Cells
0.165
0.078
0.013
0.124

∆ BmrA
Single
UV-vis
Cells
0.494
0.189
0.107
0.040
0.013
0.015
0.177
0.065
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Figure 19: Representative images of MIC experiment of single intracellular and
extracellular of drug nano-carriers.

AgMUNH-Oflx NPs incubated with 0.06 µM for a, b, and c and 0.0 µM d respectively,
in WT strain at 18 h. (a) 2.4 ± 0.7 nm AgMUNH-Oflx NPs and (b) 13.0 ± 3.1 nm
AgMUNH-Oflx NPs (c) 92.6 ± 4.4 nm AgMUNH-Oflx NPs and (d) cells alone. The scale
bar is 2 μm in all images.
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In Figure 20 are representative images of DFOMS of Figure 20A, 20B, 20C, and
20D was WT cells are 2.4 ± 0.7 nm, 13.0 ± 3.1 nm, 92.6 ± 4.4 nm AgMUNH-Oflx NPs
and Oflx respectively with different concentrations of Oflx. Concentration of AgMUNHOflx NPs (drug nano-carriers) were converted to Oflx concentrations based on the
conjugation ratio, 0.06, 0.11, 0.22, 0.42, and 0.72 µM from a-e, whereas f is 0.72 µM of
AgMUNH2 in Figure 20A, 20B, 20C, and 0.0 µM of Oflx in Figure 20D. As the
concentration of Oflx increased we saw less number of bacteria with 2.4 ± 0.7 nm
AgMUNH-Oflx NPs. Figure 20A bacteria cell growth is only three concentrations 0.06,
0.11, 0.22 µM, for 13.0 ± 3.1 nm AgMUNH-Oflx NPs as shown in Figure 20B bacteria
growth only in 0.06 and 0.11 µM, for 92.6 ± 4.4 nm AgMUNH-Oflx NPs as shown in
Figure 20C bacteria growth only in 0.06 µM for Oflx as shown in Figure 20D bacteria
growth in 0.06, 0.11, 0.22 µM concentrations. In contrast to these, AgMUNH2 NPs grew
almost the same as 0.0 µM of Oflx. The concentration of AgMUNH2 was 0.72 µM, the
highest concentration we used for the treatment of bacteria cells. In Figure 20 Af, 20 Bf,
20 Cf cells grew to the same extent as 0.0 µM of Oflx, indicating that AgMUNH 2 NPs are
biocompatible. From this, we can conclude that Ag NPs toxic effects are lowered by
functionalizing with the MUNH2 group. This is important for application of Ag NPs in the
diagnosis and for making NPs biocompatible to reduce toxicity.

We further counted the number of bacteria for each concentration as shown in
Figure 21A as WT, Figure 21B as ΔBmrA a, b, c with 2.4 ± 0.7, 13.0 ± 3.1 and 92.6 ±
4.4 nm AgMUNH2 NPs. Whereas d, e, f, g are 2.4 ± 0.7 nm AgMUNH-Oflx NPs, Oflx,
13.0 ± 3.1 nm AgMUNH-Oflx and 92.6 ± 4.4 nm AgMUNH-Oflx NPs, used cumulative of
three runs.65 The same phenomenon was seen in Figure 18 and calculated MIC50
values (Table 2) were 0.165, 0.126, 0.078, and 0.013 µM for WT, whereas for ΔBmrA
0.189, 0.065, 0.040, and 0.015 µM for 2.4 ± 0.7 nm AgMUNH-Oflx, Oflx alone 13.0 ± 3.1
nm AgMUNH-Oflx and 92.6 ± 4.4 nm AgMUNH-Oflx respectively.
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Figure 20: Representative images of WT cells after 18 h incubation showed dose
and size dependent antimicrobial activities.

The cells incubated with (A) 2.4 ± 0.7; (B) 13.0 ± 3.1; (C) 92.6 ± 4.4 nm AgMUNH 2-Oflx
at concentration (a) 0.06, (b) 0.11, (c) 0.22, (d) 0.42 and (e) 0.72 µM indicated that as
drug concentrations increased, number of cells decreased . Differently, the cells
incubated with (A f) 2.4 ± 0.7; (B f) 13.0 ± 3.1; (C f) 92.6 ± 4.4 nm AgMUNH 2 NPs at the
maximum concentration (0.72 µM) posed a small impact on cell growth. (D) Oflx at
concentration (a) 0.06, (b) 0.11, (c) 0.22, (d) 0.42 and (e) 0.720 (f) 0.0 µM . The scale
bars A, B,C, D are 5 µm.
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Figure 21: Plot of # of Cells (y1) versus the concentration, MIC50 is calculated from
using exponential decay with y=a exp(-bx) equation at 18 h.
A and B MIC of Oflx in WT and ΔBmrA were imaged. (a) 2.4 ± 0.7 nm AgMUNH2 (b)
13.0 ± 3.1 nm AgMUNH2 (c) 92.6 ± 4.4 nm AgMUNH2 (d) 2.4 ± 0.7 nm AgMUNH-Oflx y1
WT=

527.5e(-4.575c), R2 = 0.958 ; y1 ΔBmrA= 560.3e(-4.008 c), R2 = 0.964, (e) Oflx alone y1 WT=

501.6e(-5.600c), R2 = 0.974 ; y1

ΔBmrA=

514.9e(-10.26c) R2 = 0.987 ,(f) 13.0 ± 3.1 nm

AgMUNH-Oflx y1 WT= 524.4e(-9.631c), R2 = 0.956 ; y1 ΔBmrA= 520.1e(-17.150c), R2 = 0.981 and
(g) 92.6 ± 4.4 nm AgMUNH-Oflx y1
R2 = 0.999.

WT=

496e(-55.15c), R2 = 1.00 ; y1

ΔBmrA=

526.0e(-45.36c),
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We saw a size dependent inhibitory effect in both strains. No strain dependency
was observed, which may be due to the concentration being too high or low, or the cells
may have already acquired resistance.

We saw differences in the MIC results between two unique strategies, either by
specifically measuring absorbance (optical density) at 600 nm (OD 600nm) (Figure 18) or
by counting the number of bacterial cells from single cell analysis contained slides
(Figure 21). This may be due to the volume of samples used for the preparation of
slides which was different from the volume used for measurements of optical density
and sample size.

SUMMARY:
We successfully synthesized three different sized nano-carriers (AgMUNH2 NPs)
and antibiotic drug nano-carriers (AgMUNH-Oflx NPs) of 2.4 ± 0.7 nm, 13.0 ± 3.1 nm
and 92.6 ± 4.4 nm. We studied the growth curve and efflux mechanism of cells in the
standard and modified medium. We came to the conclusion that cells are growing
normally in modified medium and that efflux function is almost same in the standard
medium. We used drug nano-carriers to study the minimum inhibitory concentration in
gram-positive bacteria B.subtilis. We saw a size-dependent inhibition of bacteria cells.
In conclusion 2.4 ± 0.7 nm AgMUNH-Oflx NPs was found to be less toxic compared with
Oflx alone. 13.0 ± 3.1 nm AgMUNH-Oflx NPs were toxic and 92.6 ± 4.4 nm AgMUNHOflx NPs were more toxic indicating that a smaller size NPs are biocompatible and can
be used in diagnosis or as a sensor whereas larger size can be used for the treatment
of diseases. As seen in dark-field optical imaging, cells did not divide properly indicating
Oflx mechanism is inhibiting DNA gyrase. We used AgMUNH2 NPs and we did not see
any inhibitory effect. Instead saw cells grow normally proving that AgMUNH2 NPs are
biocompatible. Our studied showed that the nanoparticles functionalized with the drug
and demonstrated a size-dependent and antimicrobial effect. These findings suggest
that nanoparticles functionalized with drugs are an effective way to treat of infectious
diseases and cancer. The dosage of a drug can be lowered significantly when
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functionalized with nanoparticles which in turn, could reduce side effects of the drug
alone. We can functionalize nanoparticles with certain polymers in such a way that the
drug is released only in the targeted site. We would like to study efflux function of ABC
transporter antibiotic drug nano-carriers in B.subtilis.

METHODS
Reagents and Supplies
Silver nitrate (99.9%), sodium citrate dihydrate (99%), sodium borohydride
(98%), hydrogen hydroxide (30%), polyvinylpyrrolidone (PVP), sodium chloride, sodium
phosphate , sodium phosphate monobasic monohyrdate, 11-amino-1-undecanethiol
hydrochloride (MUNH2, 99%), Luria-broth (LB) powder, yeast extract, sodium chloride
and 2-(N-morpholino)ethanesulfonic acid were purchased from Sigma-Aldrich. Ofloxacin
powder (≥98%) purchased from Enzo life science 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC, 99%) and N-hydroxysulfosuccinimide (sulfo-NHS,
98.5%) were purchased from Pierce. Silver perchlorate monohydrate (99%) was
purchased from Alfa Aesar. Live/dead BacLight viability and counting assay, Hoechst
were purchased from Invitrogen. All reagents were used as received. The nanopure
deionized (DI) water (18 MΩ water, Barnstead) to prepare solutions, including a
commonly used LB medium (1% tryptone, 0.5% yeast extract and 0.5% NaCl in DI
water, pH = 7.2) and a modified LB medium (1% tryptone, 0.5% yeast extract and 0.1%
NaCl in DI water, pH = 7.2).

Cell Lines, Cell Culture Media, Cell Culture, and Characterization
Two strains of gram-positive bacterial cells (Bacillus subtilis): WT (normal
expression BmrA) purchased from Bacillus Genome stock center (BGSC) and Delta
BmrA previously named as ΔYvcC, a mutant strain that is devoid of the BmrA were
provided by J. M. Jault.66 were used for this study. We first pre-cultured the cells in the
commonly used medium for 12 h. We then cultured the cells using standard LB medium
and the modified LB medium in a shaker (MaxQ 5000, 200 rpm, 37 °C) for another 8 h.
We followed the cell growth in each respective medium over time and characterized the
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cell growth curves by measuring OD600

nm

of cell suspension in the medium every 30

min over 8 h of cell culture. We studied the viability of the cultured cells by the end of
cell culture at single cell resolution using live/dead BacLight viability and counting
assay.46 The cells in the medium were imaged in the micro-chamber using dark-field
optical microscopy and epi-fluorescence microscopy. The green fluorescence cells
(peak wavelength of fluorescence spectra of SYTO9, λmax = 520 nm) and red
fluorescence cells (peak wavelength of fluorescence spectra of propidium iodide, λ max =
610 nm) were determined and counted as live and dead cells, respectively.
By the end of the cell culture, we harvested the cells using centrifugation
(Beckman JA-14, 7500 rpm), and rinsed them with the PBS buffer (0.5 mM phosphate
buffer, 1.5 mM NaCl, pH 7.2) three times via centrifugation. We then suspended the
cells in the PBS buffer and adjusted the cell suspension concentration (OD600 nm = 0.1)
in the buffer. We characterized the efflux function of BmrA membrane transporters of
live cells cultured in each medium by continuously measuring fluorescence intensity of
Hoechst dye of the cell suspension (OD600

nm

= 0.1) containing 2 µM Hoechst dye in

real-time (3 s time interval) for 2 h using a fluorescence spectrometer (Perkin-Elmer
LS50B) with the excitation and emission wavelengths at 350 and 488 nm, respectively.

Synthesis and Characterization of Ag NPs
Three different sized Ag NPs with diameters of (2.4 ± 0.7), (13.0 ± 3.1), and (92.6
± 4.4) nm were synthesized, purified and characterized as we reported previously.35, 37,
40

Briefly, we synthesized Ag NPs with diameters of 2.4 ± 0.7 nm by adding NaBH4 (150

μL, 100 mM) into a stirring mixture (42.3 mL) of silver nitrate (0.11 mM), sodium citrate
(1.91 mM), PVP (0.052 mM), and hydrogen peroxide (25 mM) that were freshly
prepared using nanopure water.35,

37

We stirred the solution at room temperature for

another 3 h and filtered the solution using 0.2 μm membrane filters. We prepared Ag
NPs with diameters of 13.0 ± 3.1 nm by rapidly adding ice-cold AgClO4 (2.5 mL of 10
mM) into a stirring ice-cold mixture (247.5 mL) of sodium citrate (3 mM) and NaBH4 (10
mM). We stirred the solution at room temperature for 4 h, and filtered it using 0.2 µm
filter.40 We synthesized (92.6 ± 4.4) nm Ag NPs by adding sodium citrate (10 mL, 34
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mM) into a refluxing (100C) aqueous solution of 3.98 mM AgNO3 (500 mL). We stirred
the mixtures for 35 min, and cooled the solution to room temperature. We then added
additional 2.5 mM sodium citrate as a stabilizer into the solution, and filtered the solution
using 0.2 µm filter.40
We purified each NP solution by thoroughly washing the NPs three times with the
DI water using centrifugation immediately after the synthesis. We characterized the NP
concentrations, the LSPR images and spectra of single NPs, and sizes of single NPs
using UV-vis spectroscopy (Hitachi U-2010), dark-field optical microscopy and
spectroscopy (DFOMS), high-resolution transmission electron microscopy (HRTEM)
(JEOL, JEM-2100F). Our setup for DFOMS is explained in our previous studies. 32, 35-38,
40, 42-44, 48-49

Our DFOMS is equipped with a dark-field optical microscope, which includes

a dark-field condenser (oil 1.43–1.20, Nikon) and a 100× objective (Nikon Plan fluor
100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth of field (focus) of 190 nm, a
charge coupled device (CCD) camera (Micromax, Roper Scientific) and Multispectral
Imaging System (Nuance, CRI). 37 ,50

Synthesis and Characterization of Drug Nano-Carriers (AgMUNH-Oflx NPs)
We added MUNH2 (1 mL, 100 mM, in ethanol) into each of the freshly prepared
Ag NPs (100 mL, 50 nM, 3.3 nM and 30 pM) of three different sized Ag NPs (2.4 ± 0.7,
13.0 ± 3.1, and 92.6 ± 4.4 nm), respectively. We stirred the mixtures for 24 h to attach
MUNH2 onto the surface of NPs via the interaction of thiol groups with the NPs to
prepare functional AgMUNH2 NPs. We washed the AgMUNH2 NPs thoroughly three
times with nanopure water to remove excess MUNH2 using centrifugation (Beckman
Optima L90k, 4 C). We suspended the half of AgMUNH2 NPs solution (50 mL) in the 2(N-morpholino) ethanesulfonic acid (MES) buffer (50 mM, pH 5.0) right before
conjugating them with Oflx. We suspended the other half of AgMUNH2 NPs solution (50
mL) in the PBS buffer (pH 7.0) right before control experiment. Note that the AgMUNH2
NPs were suspended in DI water for the storage, and only suspended in the respective
buffer right before the experiment. After each washing and re-suspension step, we
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immediately characterized the concentrations, optical properties and sizes of each sized
AgMUNH2 NPs using UV-vis spectroscopy, DFOMS and DLS, respectively.
We then conjugated the amine groups of each sized AgMUNH2 NPs (50 mL) with
the carboxyl group of Oflx via peptide bonds using a two-step method via EDC and sNHS as mediators (Fig. 12).

67-68

We first dissolved Oflx in 0.5 M HCl (1 mL) and then

diluted it using MES buffer (pH 5.0). We added the EDC (100 μL, 100 mM) and s-NHS
(100 L, 500 mM) into the Oflx solution (3 mL, 50 mM), and stirred it at room
temperature for 40 min, to form Oflx-s-NHS esters. We added 2-mercaptoethanol (10
μL,14.3 M) to quench the excess EDC. We added the Oflx-s-NHS esters (1 mL, 3 mM)
to the AgMUNH2 NPs (100 mL, 50 nM for 2.4 nm, 3.3 nM of 13 nm and 30 pM for 93 nm
NPs, in the MES buffer, pH 5.0), and well mixed the solution using a rotary shaker at
room temperature for 3 h, to synthesize the AgMUNH-Oflx NPs, respectively.
We purified the drug nano-carriers (AgMUNH-Oflx NPs) by washing the nanocarriers with DI water three times and stored at 4C for the future use. We suspended
each sized nano-carrier in the PBS buffer (pH 7.0) right before the experiment for the
study of their inhibitory effect on cell growth. After each washing and right after NPs
suspended in the solution, we immediately characterized the concentrations, optical
properties and sizes of each sized AgMUNH2 NPs using UV-vis spectroscopy, DFOMS
and DLS, respectively. We measured the UV-vis absorbance spectra of various
concentrations of each sized nano carriers (AgMUNH-Oflx NPs) in the solution and
plotted the peak absorbance of the NPs versus nano-carriers concentration to construct
a calibration curve and determine its absorption coefficients for 2.4 ± 0.7, 13.0 ± 3.1 and
92.6 ± 4.4 nm, respectively.
We measured the UV-vis absorbance spectra of various concentration of Oflx
alone (absence of NPs) in the solution, and plotted the peak absorbance at 288 nm
versus Oflx concentration to construct a calibration curve and determine its absorption
coefficient (ε288 nm = 7.8x103 M-1cm-1 and ε330 nm = 2.4x103 M-1cm-1). We subtracted UVvis absorption spectra of AgMUNH2 NPs from that of the same sized and concentration
of AgMUNH-Oflx NPs to obtain UV-vis absorption spectra of Oflx conjugated with the
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AgMUNH2 and used absorption coefficient of Oflx to determine its concentration. We
also determine the NP concentration based upon the peak absorbance of the plasmonic
absorption spectra of the NPs. By dividing the concentration of Oflx with concentration
of NPs in the same AgMUNH-Oflx NPs solution using UV-vis absorption spectroscopy,
we determined conjugation ratios of antibiotics (Oflx) to NPs for each sized drug nano
carriers.

Inhibitory Effects of Drug Nano-Carriers at Single Cell Resolution
We cultured the cells (WT or ΔBmrA) in the modified LB medium (4 mL)
containing a dilution series of Oflx alone, a given sized drug nano-carriers (AgMUNHOflx NPs) and AgMUNH2 NPs (control experiments) by inoculating 104 pre-cultured cells
into the medium, and vigorously shaking the solution (200 rpm, 37oC) over 18 h.
The dilution series contains 0, 0.06, 0.11, 0.22, 0.42, and 0.72 μM of free Oflx or
Oflx conjugated with the NPs (AgMUNH-Oflx NPs) for WT and ΔBmrA, which is
correlated with the concentrations of drug nano-carriers (NP concentrations): (i) 0.06,
0.13, 0.25, 0.49, and 0.83 nM for diameters of NPs of (2.4 ± 0.7) nm with ratio of
8.6x102 Oflx molecules per NP; (ii) 5.83x10-3, 1.17x10-2, 2.33x10-2, 4.45x10-2, and
7.63x10-2 nM for diameters of NPs of (13.0 ± 3.1) nm with ratio of 9.4x103 Oflx
molecules per NP; (iii) 8.49 x10-2, 1.71x10-1, 3.40x10-1, 6.48x10-1,and 1.11 pM for
diameters of NPs of (92.6 ± 4.4) nm with ratio of 6.4x105 Oflx molecules per NP. The
control experiments include the LB medium alone (absence of the cells) and the WT
cells cultured under the same condition and at the same time in the medium containing
0.83 nM, 7.63x10-2 nM or 1.11 pM AgMUNH2 NPs (in the absence of Oflx) with the
diameters of Ag NPs of (2.4 ± 0.7, 13.0 ± 3.1 or 92.6 ± 4.4 nm), respectively.

We sampled the cell culture suspension every 6 h and quantitatively determined
the cell concentration by measuring OD600

nm

in the cuvette using UV-vis absorption

spectrometer and imaging the number of single cells in a micro-chamber using darkfield optical microscopy. We plotted OD600

nm

and the number of the cells of the cell
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suspension over time to determine the duration that is needed for the cells to reach the
confluence. We then plotted OD600 nm and the number of the cells of the cell suspension
at 18 h versus the concentration of Oflx alone, or a given sized drug nano-carriers or
AgMUNH2 NPs to determine the minimum inhibitory concentration (MIC) of Oflx and the
given drug nano-carriers for each cell strain.
Data Analysis and Statistics
We characterized sizes and shapes of Ag NPs using TEM, and LSPR spectra of
single Ag NPs, AgMUNH2 NPs, and AgMUNH-Oflx using DFOMS. For each size and
each type of the NPs, we imaged a minimal of 100 NPs for each measurement, and
repeated each experiment three times. Thus, a minimal of 300 NPs was characterized
using TEM and DFOMS.
For single cell imaging experiment, we sampled the cell culture suspension every
6 h over 18 h and imaged single cells in a micro-chamber using dark-field optical
microscopy. We acquired five representative images of each cell culture suspension in
the same detection volume to track the cell growth in the medium and to study the
concentration, time, size, and BmrA strain dependent inhibitory effects of Oflx and nanocarriers. Each experiment was repeated three times. We used average of three
measurements with standard deviations for UV-vis whereas as for imaging used
cumulative of three runs for each sized of drug nano-carriers to determine the MIC.
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CHAPTER IV
STUDY OF EFFLUX FUNCTION OF MULTIDRUG MEMBRANE TRANSPORTERS OF
SINGLE BACILLUS SUBTILIS LIVE CELLS USING 2.0 NM DRUG-NANO-CARRIERS
INTRODUCTION:
Quinolones are broad spectrum antimicrobial agents used for the treatment of
chronic bronchitis, urinary tract infections, and sexually transmitted diseases.51,3 As
research advances quinolone derivatives are developed to reduce side effects and
increase the bioavailability of drugs; among them is fluoroquinolone such as ofloxacin
(Oflx).52 Studies have shown that resistances for antimicrobials or other drugs are
dependent on efflux out of cells through ABC transporters. The ABC transporters
constitute one of the largest and most diverse membrane protein super-families found in
living organisms.62 The ABC transporter is involved in efflux of substances either in a
unidirectional or bidirectional manner even against concentration gradients are
remarkably associated with resistance to drugs in humans.62 This raises a major
concern in treatment of disease.62 The ABC transporter contains four domains: two
transmembrane domains (TMD) which specifically bind to substrates, and two
nucleotide-binding domains (NBD) which bind to ATP to release energy driving
extrusion of the drug from the cell.
Currently, nanoparticles have a wide variety of applications in multiple fields. 54
Metal nanoparticles have peculiar physical and chemical properties when compared
with bulk metals, hence their synthesis and applications in the biomedical field have
increased drastically in the last decade.54 In the biomedical field, they are used for
sensing, drug delivery, and for therapeutic effects.58 Silver nanoparticles (Ag NPs) with
unique optical, electronic, and antibacterial properties have been widely used in biosensing, photonics, electronics, and antimicrobial applications, among others. 55, 58 In the
clinical field, Ag NPs are used as surgical dressings, for wound healing, and as antineoplastic. Some of their physicochemical properties such as size, shape, and surface
charge are important to determining the biological interaction.54,

50
Silver nanoparticles (Ag NPs) have unique optical properties, notably localized
surface plasmonic resonance (LSPR) which is the size dependence of the optical color
allowing for size characterization.34,

36, 39

This is an important phenomenon to ensure

nanoparticles are of correct size. Metal nanoparticles also do not exhibit photo-blinking
or photo-decomposition, which is crucial when monitoring cells for long durations, since
the intensity of nanoparticles will be constant.34, 36, 39, 61-63 Furthermore, the surfaces of
nanoparticles can be modified to identify a certain type of cells.35 Our group has
developed a wide range of colored single-molecule nanoparticle optical probes and
biosensors (SMNOBS) that are utilized for the imaging and characterization of
molecular mechanisms in single live cells.59
In previous studies, we studied the efflux function of Ag NPs with average
diameters of 13.1 ± 2.5 nm and 91.0 ± 9.3 nm in P.aeruginosa (a gram-negative
bacteria).40 We also studied the efflux function of Ag NPs with an average diameter of
11.8 ± 2.6 nm and 97 ± 13 nm in B.subtilis (gram-positive bacteria).39,38 Recently, we
used Ag-peptides positively and negatively charged, with diameters of 11.5 ± 2.9 nm
and 11.3 ± 2.5 nm and studied charged-dependent efflux function in B.subtilis. 65
The study of drug efflux function of transporter allows us to investigate how
resistance is acquired by bacterial cells. We used B.subtilis (a gram-positive bacteria)
as a model organism as it has a family of 78 ABC transporters.62,63,61 In this study, we
synthesized 2.4 ± 0.7 nm AgMUNH2 NPs and AgMUNH-Oflx NPs and studied the efflux
function of NPs in two B.subtilis strain WT with a normal expression level of BmrA, and
ΔBmrA with a non-expression of BmrA. In this study, we conjugated many Oflx drug
molecules on single NPs. Thus, this study of drug carrier gives us more details about
how drugs are effluxed out cells.

Results and Discussion
We first synthesized 2.4 ± 0.7 nm Ag NPs as described in methods.37 We then
functionalized the Ag NPs using a monolayer of 11-amino undecanethiol hydrochloride
(MUNH2). We then AgMUNH2 linked with ofloxacin (Oflx) by a peptide bond between
the amine group of MUNH2 and the carboxyl group of Oflx. We then washed AgMUNH-

51
Oflx NPs to remove the unreacted Oflx. The advantages of covalent conjugation were
that NPs were stable in the buffer and the conjugation ratio remained constant.
We determined the conjugation ratio of Oflx to NP using UV-vis spectroscopy.
We constructed a calibration curve of Oflx solution with an extinction coefficient (ε) at
7.8 x 103 M-1 cm-1 at 288 nm wavelength. The UV-vis spectra of AgMUNH2 and
AgMUNH-Oflx of NPs were measured. The UV-vis spectra of conjugated Oflx were
obtained by subtracting AgMUNH-Oflx NPs spectra with AgMUNH2 NPs spectra. The
absorbance of Oflx was calculated by corresponding peak height at 288 nm which was
used to determine the concentrations of conjugated Oflx. The conjugation ratio of
AgMUNH-Oflx NPs with Oflx was calculated by dividing the concentration of Oflx by the
concentration of AgMUNH-Oflx NPs we found conjugation ratio as 1: 8.6 x 102 for NP:
Oflx.
Efflux function of single membrane Transporter in Single Live cells
The distinctive plasmonic properties (LSPR, color) of single AgMUNH-Oflx NPs
and AgMUNH2 NPs were used to study the transport of single NPs in and out of single
live cells (WT and ΔBmrA), and also to distinguish between cell debris. Cell debris does
not have LSPR and appears as white under DFOMS. DFOMS of the WT cells is shown
in Figure 22 for AgMUNH-Oflx NPs and in Figure 23 for AgMUNH2 NPs. From dark-field
images, we measured the cross section of a single bacteria cell (rod-shaped cell) with a
length of 2 µm and width of 0.5 µm. Surface and base membranes of single live cells
are imperceptible under dark-field, demonstrating that the focal plane of dark-field
empowers us to image thin-layer section of single live cells with single NPs. Since NPs
have scattering intensity this was used to determine whether NPs are intracellular or
extracellular. When NPs were inside the cell (intracellular NP) scattering intensity was
lower and NPs appeared dimmer (Fig.22,23B) whereas when outside the cell
(extracellular NP), the scattering intensity was brighter (Fig.22,23C). We proved that by
using scattering intensity we can distinguish between intracellular and extracellular NPs
allowing the study of the efflux function of single membrane transporters in real time
imaging of single live cells.34-36, 38-39, 44, 61, 63
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Figure 22: Imaging of single intracellular 2.4 ± 0.7 nm AgMUNH-Oflx NPs in single
living B.subtilis bacterial cells using DFOMS.
(A) The representative image of WT bacterial cells incubated with 1.4 nM AgMUNH-Oflx
NPs showing intracellular drug nano-carriers as squared. (B) Zoom-in images of single
WT cells show (i, iii) are CCD images pseudo colors were added and (ii, iv) color
images intracellular AgMUNH-Oflx NPs. (C) Zoom-in images of single WT cells show (i,
iii) are CCD images pseudo colors were added and (ii, iv) color images extracellular
AgMUNH-Oflx NPs. The scale bar in A and B are 10 and 2 µm, respectively. (D) LSPR
spectra of 2.4 ± 0.7nm AgMUNH-Oflx NPs show peak wavelength at 568 nm and 586
nm.
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Figure 23: Imaging of single intracellular 2.4 ± 0.7nm AgMUNH2 NPs in single
living B.subtilis bacterial cells using DFOMS.
(A) The representative image of bacterial WT cells incubated with 1.4 nM AgMUNH2
NPs showing intracellular nano-carriers as squared. (B) Zoom-in images of single WT
cells show (i, iii) are CCD images pseudo colors were added and (ii, iv) color images
intracellular AgMUNH2 NPs. (C) Zoom-in images of single WT cells show (i, iii) are CCD
images pseudo colors were added and (ii, iv) color images extracellular AgMUNH2 NPs.
The scale bar in A and B are 10 and 2 µm.
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Accumulation Rates of Intracellular AgMUNH-Oflx and AgMUNH2 NPs in BmrA
We examined the accumulation rates of AgMUNH-Oflx NPs and AgMUNH2 NPs
in both WT and ΔBmrA to determine the rate of accumulation of NPs in single BmrA live
cells. The results in Figure 24 and Table 3 show accumulation rates calculated from the
slope of the plot of intracellular NPs in single BmrA cells. The accumulation rate of 1.4
nM AgMUNH-Oflx NPs in WT was 0.43 NPs/min, whereas with AgMUNH2 NPs was
0.74 NPs/ min at 41.5 min. The ratio of AgMUNH-Oflx to AgMUNH2 is 0.6. In ΔBmrA the
accumulation rates were 0.86 NPs/ min and 1.39 NPs/min for AgMUNH-Oflx and
AgMUNH2 NPs respectively, at 41.5 min. The ratio of AgMUNH-Oflx to AgMUNH2 NPs
was also 0.6. As ΔBmrA was a devoid of pump activity, it accumulated more NPs inside
the cells.

Table 3: Study of Accumulation Rates and Number of Intracellular Single 2.0 nm NPs in
Single Live Cells

Diameter
(nm)a

C NPs
(nM)
1.4 nM

2.4 ±0.7
0.7 nM

NPs
AgMUNH-Oflx
AgMUNH2
AgMUNH-Oflx
AgMUNH2

Accumulation
Rate (NPs min-1)b
WT
0.43
0.74
0.38
0.29

ΔBmrA
0.86
1.39
0.49
0.98

Number of
Intracellular NPs
(min)c
WT
ΔBmrA
33
70
60
114
32
39
25
83

a

Diameter of Ag NPs measured by TEM;

b

Accumulation rates (slopes of plots) of the NPs in 900 live cells over 41.5 min (Figure

25 and 26);
c

Number of intracellular NPs accumulated in 900 live cells at 41.5 min incubation
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Figure 24: Study of accumulation kinetics of single AgMUNH-Oflx NPs and
AgMUNH2 NPs in single live cells.
Plots of number of intracellular NPs in (A) WT and (B) ΔBmrA cells (a) 1.4 nM
AgMUNH2 NPs (b) 1.4 nM AgMUNH-Oflx NPs were incubated for 2 h. The points
represent the sum of three repeated experiments.
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Entry of NPs into the cells was not hindered by AgMUNH-Oflx NPs or AgMUNH2
NPs. AgMUNH-Oflx NPs accumulated less than AgMUNH2 NPs in both strains,
indicating that the AgMUNH-Oflx NPs is also extruded much faster than the AgMUNH2
NPs. Moreover, in bacterial cells (B.subtilis) do not have alternative mechanisms such
as endocytosis, pinocytosis, and exocytosis mechanism for efflux of substrates.
Concentration-dependent accumulation rates of single AgMUNH-Oflx and
AgMUNH2 NPs in BmrA.
We were also interested in knowing whether the NPs conjugated with antibiotics have
similar characteristics of concentration-dependent efflux kinetics as antibiotics alone.
The results from Figure 25 show that as concentration increased from 0.7 nM to 1.4 nM,
the number of intracellular AgMUNH-Oflx NPs increased from 39 to 70 in single live
ΔBmrA with accumulation rates of 0.49 and 0.86 NPs/min respectively; from this we can
conclude that accumulation of NPs in single live ΔBmrA increased proportionally with
concentration of AgMUNH-Oflx NPs. Whereas as in single live WT the number of
intracellular AgMUNH-Oflx NPs was 32 to 33 with accumulation rates of 0.38 and 0.43
NPs/min during the first 41.5 min, indicates that the number of intracellular AgMUNHOflx does not increase with the concentration in this strain of bacteria. We also studied
efflux function of cells (WT, ΔBmrA) using Hoechst dye. Cells are incubated with 2 µm
dye and observed the time course of fluorescence intensity for 40 min. From Figure 25C
as time proceeded, from 0-15 min, the amount of Hoechst dye is accumulating more in
ΔBmrA than in WT (Figure 25Cb) and after 15 min, cells reached uptake saturation and
remained constant for 40 min, whereas in WT (Figure 25Ca) it remained constant
throughout 40 min.
In contrast with results from AgMUNH-Oflx NPs, as concentration increased from
0.7 nM to 1.4 nM the number of intracellular AgMUNH2 NPs increased from 93 to 165 in
single live ΔBmrA with accumulation rates of 0.98 and 1.39 NPs/min (Figure 26). While
in single live WT, the number of intracellular AgMUNH2 NPs increased from 26 to 60
with accumulation rate of 0.29 to 0.74 NPs/min during the first 41.5 min. The results
from AgMUNH2 NPs we can conclude that we accumulation of NPs in single live WT
increased proportionally to the concentration of AgMUNH2 NPs but not in ΔBmrA.
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Figure 25: Study of efflux kinetics of BmrA membrane transporter using 2.4 ± 0.7
nm AgMUNH-Oflx NPs.
(A) Plots of number of intracellular AgMUNH-Oflx NPs in B.subtilis incubated with 1.4
nM (a) ΔBmrA and (b) WT. (B) The number of intracellular AgMUNH-Oflx NPs in
B.subtilis incubated with 0.7 nM (a) ΔBmrA and (b) WT were plotted over time. (C) Time
course of fluorescence intensity of intracellular Hoechst dye for (a) ΔBmrA and (b) WT
cells incubated with 2 µM Hoechst dye for 40 min (Ex : 350 nm and Em : 488 nm)
showed accumulation of intracellular Hoechst dye depends on the expression of
B.subtilis.
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Figure 26: Study of efflux kinetics of BmrA membrane transporter using 2nm
AgMUNH2 NPs.
(A) Plots of number of intracellular AgMUNH2 in B.subtilis incubated with 1.4 nM (a)
ΔBmrA and (b) WT (B) Plots of number of intracellular AgMUNH2 NPs in B.subtilis
incubated with 0.7 nM (a) ΔBmrA and (b) WT.
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Taken together, the results suggest that with AgMUNH-Oflx NPs showed concentrationdependent efflux kinetics as antibiotics even though we functionalized with 8.6x10 2 Oflx
on single NPs. These finding indicate that AgMUNH-Oflx NPs enter the cell through
passive diffusion and efflux out leading to lower accumulation rates in WT when
compared with ΔBmrA (devoid of pump). Interestingly, the results show that even such
smaller size NPs (2.4 ± 0.7 nm) can be effluxed out and can be used as diagnosis
probes. To our knowledge, no one has reported efflux kinetics with such smaller sized
NPs and functionalized with AgMUNH-Oflx along with AgMUNH2 (control NPs).

Characterization of Viability of Single Live Cells
The viability of single cells with NPs is very important since NPs are
functionalized with MUNH2 and Oflx. We incubated cells (WT, ΔBmrA) with NPs
(AgMUNH-Oflx and AgMUNH2) for 2 h and at the end of the experiment; the viability of
cells was measured by using a live/dead BacLight assay. This assay contained two
fluorescent dyes: SYTO9 a green fluorescent (λmax = 520 nm) in which the nucleic acid
stain in live cells appears in green fluorescence. Propidium iodide is a red florescent
(λmax = 610 nm) which penetrates into damaged or disintegrated cells appearing in red
fluorescence. Figure 27 shows representative optical images (Fig 27a) and green
fluorescence (Fig 27b) of ΔBmrA and WT with and without AgMUNH-Oflx NPs in single
cells. We counted the number of live and dead cells and calculated percentage of viable
cells by dividing the number of live cells over the total number of the cells. Results
showed that 99-100% of cells viable for both strains (Fig 27C). Figure 28 shows
representative optical images (Fig 28a) and green fluorescence (Fig 28b) of ΔBmrA and
WT with and without AgMUNH2 NPs in single cells. Results showed that 98-100% of
cells viable for both strains (Fig 28C). From these viability assays, we can conclude that
both AgMUNH-Oflx and AgMUNH2 are biocompatible to cells at the concentration of 1.4
nM.
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Figure 27: Characterization of the viability of single bacterial cells using live/dead
Baclight viability and counting assay.
(a) Dark-field optical image and (b) fluorescence image of single bacterial cells (A)
ΔBmrA (B) WT cells, incubated with 1.4 nM AgMUNH-Oflx NPs over the duration of
each experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9,
indicating that cells are viable. (C) Plots of percentage of viable cells incubated with (a,
b) 1.4 nM AgMUNH-Oflx NPs and (c, d) 0.7 nM AgMUNH-Oflx NPs, indicate that 99100% of the cells are alive. Minimum 300 cells were assayed and analyzed. The scale
bar is 5 µm.
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Figure 28: Characterization of the viability of single bacterial cells using live/dead
BacLight viability and counting assay.
(a) Dark-field optical image and (b) fluorescence image of single bacterial cells (A)
ΔBmrA (B) WT cells, incubated with 1.4 nM AgMUNH2 NPs over the duration of each
experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, indicating
that cells are viable. (C) Plots of percentage of viable cells incubated with (a, b) 1.4 nM
AgMUNH2 NPs and (c, d) 0.7 nM AgMUNH2 NPs, indicate that 99-100% of the cells are
alive. Minimum 300 cells were assayed and analyzed. The scale bar is 5 µm.
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SUMMARY
We successfully synthesized 2.4 ± 0.7 nm Ag NPs, then functionalized them with
a monolayer of MUNH2 and finally linked with Oflx via an amine group of AgMUNH2 NPs
and the carboxyl group of Oflx by a peptide bond, to prepare AgMUNH-Oflx NPs. We
found that the number of Oflx molecules on a single NP is 8.6x102 and used LSPR
spectra to track the NPs in order to study the efflux function. We found that cells were
biocompatible up to 1.4 nM concentrations and used this concentration to study the
efflux kinetics in ABC transporter of B.subtilis in a single cell. We found the efflux of
AgMUNH-Oflx NPs is slower when compared with AgMUNH2 NPs. The accumulation
rates in WT (0.43 NPs/min) and ΔBmrA (0.86 NPs/min) for 1.4 nM AgMUNH-Oflx NPs,
WT (0.74 NPs/min), and ΔBmrA (1.39 NPs/min) for 1.4 nM AgMUNH2 NPs, and the ratio
of accumulation of AgMUNH-Oflx to AgMUNH2 NPs was found to be 0.6 for both
strains. We also found a concentration-dependency in ΔBmrA treated with AgMUNHOflx NPs, while WT cells did not , indicating that these nano-carriers also effluxed out
similarly to antibiotics. To our knowledge, no one had studied efflux function using
smaller sized NPs (2.4 ± 0.7 nm Ag NPs). We have already studied Ag NPs as probes
to study efflux function and from this, we have proved even smaller nano-carriers can
be used study efflux function. We further need to study larger sized drug nano-carriers
(10-100 nm NPs) to determine the efflux function in ABC Transporter.

METHODS
Reagents and Supplies
Sodium citrate dihydrate (99%), sodium borohydride (98%), hydrogen hydroxide
(30%),

polyvinylpyrrolidone

(PVP),

2-mercaptoethanol

(99%),

11-

mercaptoundecylamine (MUNH2, 99%), sodium chloride, sodium phosphate, sodium
phosphate monbasic monohydrate, tryptone, yeast extract were purchased from SigmaAldrich. Ofloxacin powder (≥98%) purchased from Enzo life science. 1-Ethyl-3-[3dimethylaminopropyl]-carbodiimide

hydrochloride

(EDC,

99%)

and

N-

hydroxysulfosuccinimide (sulfo-NHS, 98.5%) were purchased from Pierce. Silver
perchlorate monohydrate (99%) was purchased from Alfa Aesar. Live/dead BacLight
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viability and counting assay, Hoechst 33342 dyes were purchased from Invitrogen. All
reagents were used as received. The nanopure water (18.0 M water, Barnstead) was
used to prepare all solutions and rinse glassware.
Synthesis and Characterization of NPs
As we described in previous papers, briefly 2.4 ± 0.7 nm Ag NPs were
synthesized by preparing AgNO3 (0.11 mM), sodium citrate (1.91 mM), PVP (0.052
mM), and H2O2 (25.0 mM) in nanopure water (42.3 mL) mixed and stirred constantly,
then NaBH4 (150 μL, 100 mM) was added into the mixture, the solution color turned to
light yellow, all solution were prepared freshly. After stirring for another 3 h, the solution
was filtered using 0.2 μm membrane filters. The Ag NP solution was immediately
washed using centrifugation and characterized using UV-vis spectroscopy (Hitachi
U2010), our dark-field single nanoparticle optical microscopy and spectroscopy
(SNOMS). TEM samples were immediately prepared and further characterized using
high- resolution transmission electron microscopy (HRTEM) (FEI Tecnai G2 F30 FEG).
Our Dark-field Optical Microscopy (DFOMS) is equipped with a dark-field optical
microscope, which includes a dark-field condenser (oil 1.43–1.20, Nikon) and a 100×
objective (Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth
of field (focus) of 190 nm, a CCD camera (Micromax, Roper Scientific) and Multispectral
Imaging System (Nuance, CRI).

37,50

We explained development and application of

DFOMS have been fully described in our previous studies.34-39, 42-44, 48, 50
Synthesis of AgMUNH2 NPs
MUNH2 (100 mM) in 1 mL ethanol was added to 100 mL of 2.4 ± 0.7 nm Ag NPs
solution. The solutions then were stirred for 24 h to attach MUNH2 onto the surface of
Ag NPs via their interaction of thiol groups with NPs. The AgMUNH2 NPs were washed
twice by nanopure water to remove excess MUNH2 using centrifugation 30,000 rpm at
4ºC for 60 min. The AgMUNH2 NPs were immediately characterized using UV-vis
spectroscopy and DFOMS.
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Synthesis of AgMUNH-Ofloxacin NPs (AgMUNH-Oflx)
An amine group of AgMUNH2 NPs was conjugated to a carboxyl group of
ofloxacin via a peptide bond using EDC and sulfo-NHS as mediators.67-68 Initially,
ofloxacin powder was dissolved in 0.5 M HCl and diluted to 10 mM using MES buffer
(50 mM, pH 5.0). EDC (30 μmol) and sulfo-NHS (150 μmol) were added into the
ofloxacin solution (3 mL, 50 mM) which then was kept stirring for 40 min allowing Oflx-sNHS esters to form. The reaction was stopped by adding 10 μL of 2-mercaptoethanol.
To link AgMUNH2 with Oflx-s-NHS, 1 mL Oflx-s-NHS esters were mixed with 100 mL
AgMUNH2 of each different NPs size using a rotary shaker for 3 h at room temperature.
The final products (AgMUNH-Oflx) were washed with 50 mM PBS using centrifugation
.The pellets were redispersed in 50 mM PBS and stored at 4ºC for future use. The sizes
and optical properties were characterized using UV-vis spectroscopy and DFOMS.
Cell Culture and Preparation
The Bacillus subtilis cell lines using in this study are as follows: WT (BmrA) were
purchased from Bacillus Genome Stock Center (BGSC), while ΔBmrA (previously
named as ΔYvcC, a mutant strain that is devoid of the BmrA) were provided by J. M.
Jault.66
We pre-cultured the cells in an Erlenmeyer flask (250 mL) containing 20 mL of Lbroth (LB) medium (1% tryptone peptone, 0.5% yeast extract, and 0.5% NaCl, pH = 7.2)
in a shaker (MaxQ 5000 floor-Model Shaker) (160 rpm, 37C) for 12 h. We then cultured
the cells (WT and ΔBmrA) in the LB medium for another 8 h. We harvested the cultured
cells using centrifugation (Beckman Model J2-21,JA-14 rotor, at 7000 rpm, 23°C, 10
min), washed the cells in PBS buffer three times, and finally re-suspended the cells in
PBS buffer. The final concentration of the cells was adjusted to OD600 nm = 0.7, and used
for the entire study.
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Bulk Imaging of Single NPs in Single Living Cells
The cell suspension (OD600nm = 0.7) containing 1.4 nM and 0.7 nM AgMUNH-Oflx
NPs and AgMUNH2 NPs were prepared. The timer was started to record the incubation
time as the NPs were added into the cell suspension. Following NP addition, we
transferred the mixture (1.0 μL) into a freshly prepared micro-chamber (using nail
polish) every 25 min and using DFOMS we imaged the cells at eighteen representative
locations. This approach permitted us to image the massive amount of cells ( minimum
of 10 cells per location for every 18 locations we usually get 18*10=180 bacteria cells)
for each sample to gain sufficient statistics for probing the accumulation and efflux
kinetics of bulk cells at single cell resolution. We determined intracellular NPs and
plotted them versus time to measure accumulation rates of single NPs for the cells over
time (accumulation rate = slope of the plot).
Fluorescence spectroscopy measurements
Time-dependent of fluorescence intensity of 2.0 µM Hoechst dye incubated with
the 3.0 mL cells (WT, ΔBmrA) measured in a 3 s interval using a fluorescence
spectrometer (Perkin-Elmer LS50B). The excitation and emission wavelengths were
350 and 488 nm, respectively.
Cell Viability
At the end of each experiment, the viability of the cells was characterized using
live/dead BacLight bacterial viability and counting assay.46 We imaged the cells using
dark-field optical microscopy and epi-fluorescence microscopy, and counted the green
fluorescence cells (peak wavelength of fluorescence spectra of SYTO9, λmax = 520 nm)
and red fluorescence cells (peak wavelength of fluorescence spectra of propidium
iodide, λmax = 610 nm) as live and dead cells, respectively.
Data Analysis and Statistics
We acquired eighteen representative images of each cell suspension incubated
with 1.4 or 0.7 nM NPs every 25 min (18 min for imaging and 7 min for the preparation
of slide) for 2 h to study accumulation rates of intracellular NPs in single living cells.
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Therefore, a minimal of ~180 cells was imaged every 25 min, and 900 cells were
studied over 2 h for each measurement. Each experiment was repeated three times.
Thus, 2700 cells were studied for each sample, which allowed us to gain sufficient
statistics for probing accumulation rates and efflux kinetics of bulk cells at single cell
resolution. The equilibrium times of accumulation of NPs in the cells were determined at
the times when the accumulation rates of intracellular NPs remained unchanged over
time. The amount of accumulated intracellular NPs for each strain refers to the amount
of intracellular NPs at the equilibrium time.
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CHAPTER V
STUDY OF EFFLUX FUNCTION OF MULTIDRUG MEMBRANE TRANSPORTERS OF
SINGLE BACILLUS SUBTILIS LIVE CELLS USING 13.0 NM DRUG NANOCARRIERS

INTRODUCTION
In the treatment of bacterial diseases such as pneumonia, chronic bronchitis, and
urinary tract infections, fluoroquinolone derivatives such as ofloxacin are often used.52
However bacteria have acquired resistance towards many drugs due to multidrug
resistance (MDR).3,

52

Resistance to a drug is attributed to MDR transporter, which

extrudes drugs or other substances out of the cells. 52,5 The MDR transporter is
classified as two types which are a proton gradient and adenosine triphosphate (ATP)
binding cassette (ABC) transporter by ATP hydrolysis.1 ABC transporter is found in both
prokaryotes and eukaryotes and is involved in the transport of a variety of structurally
similar compounds.3 The ABC transporter contains two transmembrane domains (TMD)
and two nucleotide-binding domains (NBD).1, 3-5 Substrates specifically bind to the TMD
and form a passage that allows substrates to cross the membranes. ATP hydrolysis by
NBD provides energy for the transporter, which causes the substrates to efflux out of
cells against the concentration gradient.1, 4-5

The foremost question was how resistance is acquired and how structurally
similar membrane transporters could extrude structurally unrelated substrates through
ABC transporters by the efflux mechanism.1,

5

Many studies were done using x-ray

crystallography and cryo-TEM at atomic resolution.1,

5, 69

However, none of them

provided real-time information regarding how proteins specifically bind with substrates,
how they lead to a change in conformation of membrane transporters, the efflux of
substrates, or the crystallization of proteins.

Radioisotopes i.e.,

14

C or 3H and fluorescent dyes such as Hoechst dye,

ethidium bromide or rhodamine in both mammal and bacterial cells can be used to
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study the efflux kinetics of multidrug membrane tansporters.6-9 However, these present
some disadvantages such as photo-bleaching and accumulation kinetics of substrates
in bulk cells but not in single membrane cells. Hence, it is important to know efflux
kinetics of substrates at the single cell level.

Nanoparticles have become quite popular during the last decade due to their size
and physicochemical properties. They are used in multiple fields such as probesdiagnosis of diseases and isolation of cells, site specific drug delivery, and
encapsulation of drugs etc.54-58 Metal nanoparticles like Silver nanoparticles (Ag NPs)
are frequently used due to their plasmonic properties which in turn depend on the
shape, size, and dielectric constant.

54-58

Dark-field optical microscopy and

spectroscopy (DFOMS) which uses a halogen lamp as an illumination source is used to
image and characterize single Ag NPs.34-35, 37, 39-40, 43-44, 49-50, 59 In our previous studies,
we used localized surface plasmon resonance spectra (LSPR) and size-dependent
scattering intensity of single NPs to determine the quantitative size of NPs in solution,
single live embryos, and also in single live cells in real time. 34-35,

37, 39-40, 43-44, 49-50, 59

Since Ag NPs are photostable, we used them as probes to the study size-dependent
efflux mechanism of the multidrug membrane in a single live cell at nm spatial and ms
temporal resolution.

34-35, 37, 39-40, 43-44, 49-50, 59

We also functionalized the surface of NPs

with a certain monoclonal antibody in order to identify a certain type of cells. 59

In previous studies, we used Ag NPs with an average diameter of 13.1 ± 2.5 nm
and 91.0 ± 9.3 nm to study the efflux function in P.aeruginosa (a gram-negative
bacteria).40 The efflux function was also studied using 12.3 ± 1.8 nm Ag NPs in E.coli (a
gram-negative bacteria).21 We used Ag NPs with an average diameter of 11.8 ± 2.6 nm
and 97 ± 13 nm to study the efflux function in B.subtilis (a gram-positive bacteria).39,38
Recently, we also used a functionalized positively and negatively charged Ag-peptide
with a diameter of 11.5 ± 2.9 nm and 11.3 ± 2.5 nm to study the charged-dependent
efflux function in B.subtilis.65 We studied the efflux function of 2.4 ± 0.7 nm AgMUNHOflx NPs (drug nano-carriers) in B.subtilis and found that even smaller sized NPs were
effluxed out similar to antibiotics or drugs.
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One

of

the

key

challenges

for

treating

diseases

is

resistances

to

antibiotics/drugs. In this study, we used 13.0 ± 3.1 nm Ag NPs that were functionalized
with Oflx molecules. We studied the efflux function in B.subtilis to better understand this
process, which might depend on the size of nano-carriers and also on a number of
carrier molecules attached on the surface of nano-carriers.

RESULTS AND DISCUSSION
Synthesis of AgMUNH-Oflx NPs (drug nano-carriers)
We synthesized 13.0 ± 3.1 nm Ag NPs as explained in previous papers and
methods.42-43 Ag NPs were purified and then functionalized with Oflx by two-step
reaction process. First, we functionalized with a monolayer of MUNH 2, and in step 2
carboxyl group of Oflx was linked to the amine group of MUNH2 via the peptide bond.
We determined the number of Oflx attached to single NPs and found it to be 9.4x10 3.22,
60

Efflux function of AgMUNH-Oflx NPs and AgMUNH2 NPs in B.subtilis
Localized surface plasma membrane (LSPR) spectra (colors) of single AgMUNHOflx and AgMUNH2 NPs were used distinguish between cell membranes and debris,
which do not possess plasmonic properties. Thus LSPR spectra of single NPs allowed
us to identify and track the single NPs intracellular and extracellular of single live cells
(WT and ΔBmrA) using DFOMS. Dark-field optical images of single live WT cells (Fig.
29) of AgMUNH-Oflx NPs and AgMUNH2 NPs (Fig. 30) showed cross sections of single
rod-like bacterial cells. NPs appeared dimmer when NPs entered the cell membrane
(Fig. 29B) for AgMUNH-Oflx NPs and (Fig. 30B) for AgMUNH2 NPs since the scattering
intensity of NPs was lower due to the entry of NPs into the cell membrane. Dark-field
illumination passes through the cell membrane to radiate and scatter the intensity of
NPs. Intracellular NPs pass through the membrane to reach the detector and the cell
membrane absorbs and scatters photons.
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Figure 29: Imaging of single intracellular 13 ± 3.1 nm AgMUNH-Oflx NPs in single
living B.subtilis bacterial cells using DFOMS.
(A) The representative image of WT bacterial cells incubated with 1.4 nM AgMUNHOflx NPs showing intracellular drug nano-carriers as squared. (B) Zoom-in images of
single WT cells show (i, iii) are CCD images and (ii, iv) color images intracellular
AgMUNH-Oflx NPs. (C) Zoom-in images of single WT cells show (i, iii) are CCD images
were added and (ii, iv) color images extracellular AgMUNH-Oflx NPs. The scale bar in A
and B are 10 and 2 µm, respectively. (D) LSPR spectra of 13 ± 3.1 nm AgMUNH-Oflx
NPs show peak wavelength at 547 nm and 560 nm.
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Figure 30: Imaging of single intracellular 13 ± 3.1 nm AgMUNH2 NPs in single
living B.subtilis bacterial cells using DFOMS.

(A) The representative image of WT bacterial cells incubated with 1.4 nM AgMUNH2
NPs showing intracellular nano-carrier as squared. (B) Zoom-in images of single WT
cells show (i, iii) are CCD images and (ii, iv) color images intracellular AgMUNH2 NPs.
(C) Zoom-in images of single WT cells show (i, iii) are CCD images and (ii, iv) color
images extracellular AgMUNH2 NPs. The scale bar in A and B are 10 and 2 µm.
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NPs appear brighter on the membrane and stuck outside the cells (Fig. 29C) for
AgMUNH-Oflx NPs and (Fig. 30C) for AgMUNH2 NPs. We used the LSPR spectra and
scattering intensity of single NPs and monitored functionalized NPs on the surface of
NPs. In real time they were incubated with cells and transported across the cellular
membrane over time using similar approaches as mentioned in previous reports. LSPR
spectra of drug nano-carriers show in Figure 29D with peak wavelength at 547 nm and
560 nm.

If the NPs were aggregated they became the larger NPs and we would have
seen a red shift of LSPR spectra and higher scattering intensity of single NPs. If Oflx or
MUNH2 were released or detached from NPs surface, a blue shift of NPs would have
been observed. This phenomenon was not observed, indicating that the NPs were
stable in PBS buffer and in the cell over time.

Accumulation of single AgMUNH-Oflx NPs and AgMUNH2 NPs in Single Live Cells
The accumulation rates of 13.0 ± 3.1 nm AgMUNH-Oflx NPs and AgMUNH2 NPs
were studied in B.subtilis WT and ΔBmrA (devoid pump) to determine the accumulation
of intracellular NPs upon the nano-carriers type and the expression of BmrA in single
live cells. The results as shown in Figure 31 and Table 4 demonstrated that the
accumulation rate in WT (Fig. 31Ab) was 0.89 NPs/min at 41.5 min and the intracellular
NPs were found to be 70, whereas in devoid pump ΔBmrA (Fig. 31Aa) was 1.22
NPs/min at 41.5 and the intracellular NPs were found to be 101. From these, results it
can be conclude that AgMUNH-Oflx NPs are effluxed out in WT but not in ΔBmrA
indicating that drug nano-carriers are effluxed out similarly to drugs/antibiotics. This is
similar to what we have seen previously for the study of smaller nano-carriers (2.4 ± 0.7
nm). Bacteria cells do not have endocytosis, pinocytosis, and exocytosis mechanisms
so NPs are not transported in or out of cells by these mechanisms. The size of NPs was
13.0 ± 3.1 nm AgMUNH-Oflx NPs, and the conjugation ratio was 9.4x103 Oflx molecules
on each NP.
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Figure 31: Study of efflux kinetics of BmrA membrane transporter using 13 ± 3.1
nm AgMUNH-Oflx NPs.

(A) Plots of number of intracellular AgMUNH-Oflx NPs in B.subtilis incubated with 1.4
nM (a) ΔBmrA and (b) WT. (B) Plots of number of intracellular AgMUNH-Oflx NPs in
B.subtilis incubated with 0.7 nM (a) ΔBmrA and (b) WT.
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Figure 32: Study of efflux kinetics of BmrA membrane transporter using 13 ± 3.1
nm AgMUNH2 NPs.
(A) Plots of number of intracellular AgMUNH2 NPs in B.subtilis incubated with 1.4 nM (a)
ΔBmrA and (b) WT (B) Plots of number of intracellular AgMUNH2 NPs in B.subtilis
incubated with 0.7 nM (a) ΔBmrA and (b) WT.
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Cells incubated with AgMUNH2 NPs from Figure 32 and Table 4 showed that the
accumulation rate in WT (Fig. 32Ab) was 20.67 NPs/min at 41.5 min and the
intracellular NPs were 1659 for 900 cells. In ΔBmrA (Fig. 32Aa) was 28.95 NPs/min at
41.5 and intracellular NPs were 2328. From this, AgMUNH2 NPs also were effluxed out
in the same way as AgMUNH-Oflx NPs. However, AgMUNH2 NPs accumulated more
than AgMUNH-Oflx NPs indicating that NPs functionalized with Oflx are also effluxed
out in a similar manner to drugs. This further emphasized that nano-carriers are effluxed
out.

Table 4: Study of Accumulation Rates and Number of Intracellular Single 13.0 nm NPs
in Single Live Cells

Diameter
(nm)a

C NPs
(nM)
1.4 nM

13.0 ± 3.1
0.7 nM

NPs
AgMUNH-Oflx
AgMUNH2
AgMUNH-Oflx
AgMUNH2

Accumulation
Rate (NPs min-1)b

Number of
Intracellular NPsc

WT

ΔBmrA

WT

ΔBmrA

0.89
20.67
0.38
12.48

1.22
28.95
0.53
18.29

70
1669
30
941

101
2328
46
1451

a

Diameter of Ag NPs measured by TEM;

b

Accumulation rates (slopes of plots) of the NPs in 900 live cells over 41.5 min (Figure

33 );
c

Number of intracellular NPs accumulated in 900 live cells at 41.5 min incubation
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Figure 33: Study of concentration-dependent accumulation kinetics of single 13 ±
3.1 nm AgMUNH-Oflx NPs and AgMUNH2 NPs in single live cells.
Plots of number of intracellular NPs in (A, a , b ) WT and (B, a , b ) ΔBmrA cells that
were incubated with (i) 1.4 AgMUNH-Oflx NPs, (ii) 0.7 nM AgMUNH-Oflx NPs , (iii) 1.4
nM AgMUNH2 NPs (iv) 0.7 nM AgMUNH2 NPs
represent the sum of three repeated experiments.

,

(b) is zoom in of (a). The points
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Concentration-Dependent Study of Single NPs in Single Live Cells
We further characterized the entry of single NPs into single live cells in order to
determine drug nano-carriers had same characteristics of pump substrates (antibiotics).
The results in Figure 33 showed that as the concentration of AgMUNH-Oflx NPs
increased the number of intracellular NPs for both strains WT and ΔBmrA also
increased. In WT the accumulation rate at 41.5 min was 0.38 and 0.89 NPs/min for 0.7
nM and 1.4 nM respectively, which was 2.3 times higher than 0.7 nM.
In ΔBmrA, the accumulation rate at 41.5 min was 0.53 and 1.22 NPs/min for 0.7
nM and 1.4 nM respectively; even this was 2.3 times higher than 0.7 nM. From this, we
can conclude that drug nano-carriers are not effluxed out in ΔBmrA due to the absence
of BmrA transporter, whereas as in WT they are effluxed out leading to lower
accumulation rate and with a lower intracellular NPs.

Even AgMUNH2 NPs showed concentration-dependence. In Figure 33 the
accumulation rate in WT was 12.48 and 20.67 NPs/min whereas ΔBmrA was 18.29 and
28.95 NPs/ min at 41.5 min for 0.7 nM and 1.4 nM respectively. This was 1.7 and 1.6
times higher than 0.7 nM for WT and ΔBmrA. The number of intracellular NPs in WT
was 941 and 1659 for 0.7 nM and 1.4 nM indicating at least 1 NP/bacteria for 0.7 nM
and 2 NPs/ bacteria for 1.4 nM was observed at 41.5 min whereas in ΔBmrA 2
NPs/bacteria and 3 NPs/bacteria for 0.7 nM and 1.4 nM respectively.

The concentration gradient leads to passive diffusion of NPs into cell membranes
whereas NPs are effluxed out by hydrolysis of ATP upon binding with NBD of BmrA.
This data demonstrated that AgMUNH-Oflx NPs efflux out much faster than AgMUNH2
NPs.

Characterization of Viability of Single Cells
We also wanted to know the viability of single cells, if the cells were dead, and if
NPs accumulated more, thus leading to an inaccurate conclusion. We used a live/dead
BacLight assay, which contains a green fluorescent (λmax = 520 nm) nucleic acid SYTO9
to stain live cells.46

78

A

a

b

B

a

b

% Viable Cells

120.0%
100.0%

C

a

b

ΔBmrA

BmrA

c

d

80.0%
60.0%
40.0%
20.0%
0.0%

ΔBmrA

BmrA

Figure 34: Characterization of the viability of single bacterial cells using live/dead
Baclight viability and counting assay.

(A) Dark-field optical image and (B) fluorescence image of single bacterial cells (a)
ΔBmrA (b) WT cells, incubated with 1.4 nM AgMUNH-Oflx NPs over the duration of
each experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9,
indicating that cells are viable. (C) Plots of percentage of viable cells incubated with (a
,b) 1.4 nM AgMUNH-Oflx NPs and (c, d) 0.7 nM AgMUNH-Oflx NPs , indicate that 99100% of the cells are alive. Minimum 300 cells were assayed and analyzed. The scale
bar is 10 µm.
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Figure 35: Characterization of the viability of single bacterial cells using live/dead
Baclight viability and counting assay.

(A) Dark-field optical image and (B) fluorescence image of single bacterial cells (a)
ΔBmrA (b) WT cells, incubated with 1.4 nM AgMUNH2 NPs over the duration of each
experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, indicating
that cells are viable. (C) Plots of percentage of viable cells incubated with (a ,b) 1.4 nM
AgMUNH2 NPs and (c ,d) 0.7 nM AgMUNH2 NPs , indicate that 99-100% of the cells are
alive. Minimum 300 cells were assayed and analyzed. The scale bar is 10 µm.
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Thus, live cells appear in green fluorescence and a red florescent (λmax = 610 nm)
propidium iodide to penetrates into damaged or disintegrated cells appearing in red
fluorescence. Cells (WT, ΔBmrA) were incubated with NPs (AgMUNH-Oflx and
AgMUNH2) for 2 h and then live/dead BacLight assay was used to measure the viability
at the end of the experiment. Representative images of ΔBmrA Figure 34A and Figure
34B WT, optical images (Fig. 34a) and green fluorescence (Fig. 34b) with and without
AgMUNH-Oflx NPs in single cells. We calculated the percentage of viable cells by
dividing live over a total number of cells (live and dead cells).From Figure 34C indicates
that 99-100% of cells are viable for both concentration and strains, indicating AgMUNHOflx NPs are biocompatible. Images of ΔBmrA are shown in Figure 35A, and Figure
35B WT, optical images (Fig. 35a) and green fluorescence (Fig. 35b) with and without
AgMUNH-Oflx NPs in single cells. From Figure 35C indicates that 100% of cells are
viable for both concentrations and strains. Cells with AgMUNH 2 NPs had a minimum of
1 NP for lowest concentration of WT and a maximum of 4 NPs for ΔBmrA. Viable cells
were present, indicating that AgMUNH2 NPs are biocompatible.
SUMMARY
We synthesized and characterized 13.0 ± 3.1 nm AgMUNH2 and AgMUNH-Oflx
NPs. We determined the number of Oflx attached to the single NPs and found this
number to 9.4x103. We tracked single NPs using LSPR spectra to study the efflux
function of AgMUNH-Oflx and AgMUNH2 NPs of B.subtilis (WT and ΔBmrA). From
viability data, we can conclude that when studying efflux function, 98-100% cells were
live indicating that NPs (AgMUNH-Oflx and AgMUNH2) are biocompatible when cells
are incubated with 1.4 nM. From the efflux function study, a concentration-dependence
was observed in single live cells (WT and ΔBmrA). The accumulation rates in WT were
0.38 and 0.89 NPs/min and for ΔBmrA (devoid pump) 0.53 and 1.22 NPs/min when
incubated with 0.7 nM and 1.4 nM at 41.5 min. More intracellular NPs were seen in
ΔBmrA than WT indicating that AgMUNH-Oflx NPs are effluxed out by BmrA
transporter. For cells incubated with AgMUNH2 NPs the accumulation rate in WT were
12.48 and 20.67 NPs/min and for ΔBmrA 18.29 and 28.95 NPs/min when incubated
with 0.7 nM and 1.4 nM at 41.5 min. We can conclude that a higher number of
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AgMUNH2 NPs were seen when compared with AgMUNH-Oflx NPs. We can conclude
that AgMUNH-Oflx NPs are effluxed out at a much faster rate using BmrA transporter
due to the resistance of drug even though single NPs contain 9.4x10 3 oflx molecules.
These interesting findings suggest that BmrA could more effectively extrude the smaller
nano-carriers (2.4 ± 0.7 nm) than 13.0 ± 3.1nm. Therefore, these larger nano-carriers
could be used to effectively deliver the drug. We would further like to study 80-100 nm
NPs functionalized with Oflx to study size-dependence.

METHODS
Reagents and Supplies
Sodium citrate dihydrate (99%), sodium borohydride (98%), 2-mercaptoethanol
(99%), 11-mercaptoundecylamine (MUNH2, 99%), sodium chloride, sodium phosphate,
sodium phosphate monobasic monohydrate, tryptone, yeast extract were purchased
from

Sigma-Aldrich.

1-Ethyl-3-[3-dimethylaminopropyl]-carbodiimide

hydrochloride

(EDC, 99%) and N-hydroxysulfosuccinimide (sulfo-NHS, 98.5%) were purchased from
Pierce. Silver perchlorate monohydrate (99%) was purchased from Alfa Aesar.
Ofloxacin powder (≥98%) purchased from Enzo life science. Live/dead BacLight viability
and counting assay were purchased from Invitrogen. All reagents were used as
received. The nanopure water (18.0 M water, Barnstead) was used to prepare all
solutions and rinse glassware.

Synthesis and Characterization of NPs
As we described in previous papers, 13.0 ± 3.1 nm Ag NPs were synthesized by
preparing a mixture of sodium citrate (3 mM) and NaBH4 (10 mM) in 247.5 mL of nano
pure water, AgClO4 (2.5 mL, 10 mM, ice-cold) was quickly added. The solution turned
yellow color within 6 mins. The solution was kept stirring at room temperature for 4 h.
The solution was filtered using 0.2 μm membrane filters. The Ag NP solution
immediately washed using centrifugation and characterized using UV-vis spectroscopy
(Hitachi U2010), our dark-field single nanoparticle optical microscopy and spectroscopy
(SNOMS). TEM samples were immediately prepared and further characterized using
high- resolution transmission electron microscopy (HRTEM) (FEI Tecnai G2 F30 FEG).
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Our Dark-Field Optical Microscopy (DFOMS) is equipped with a dark-field optical
microscope, which includes a dark-field condenser (oil 1.43–1.20, Nikon) and a 100×
objective (Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth
of field (focus) of 190 nm, a CCD camera (Micromax, Roper Scientific) and Multispectral
Imaging System (Nuance, CRI).37,50 We explained development and application of
DFOMS have been fully described in our previous studies.

35-37, 39-40, 42-44, 48

Synthesis of AgMUNH2 NPs
MUNH2 (100 mM) in 1 mL ethanol was added to 100 mL of 13.0 ± 3.1 nm Ag
NPs solution. The solutions then were stirred for 24 h to attach MUNH 2 onto the surface
of Ag NPs via their interaction of thiol groups with NPs. The AgMUNH2 NPs were
washed twice by nanopure water to remove excess MUNH2 using centrifugation 12,000
rpm at 4ºC for 150 min. The AgMUNH2 NPs were immediately characterized using UVvis spectroscopy, DFOMS, and DLS.

Synthesis of AgMUNH-Ofloxacin NPs (AgMUNH-Oflx)
An amine group of AgMUNH2 NPs was conjugated to a carboxyl group of
ofloxacin via a peptide bond using EDC and sulfo-NHS as mediators.

67-68

Initially,

ofloxacin powder was dissolved in 0.5 M HCl and diluted to 10 mM using MES buffer
(50 mM, pH 5.0). EDC (30 μmol) and sulfo-NHS (150 μmol) were added into the
ofloxacin solution (3 mL, 50 mM) which then was kept stirring for 40 min allowing Oflx-sNHS esters to form. The reaction was stopped by adding 10 μL of 2-mercaptoethanol.
To link AgMUNH2 with Oflx-s-NHS, 1 mL Oflx-s-NHS esters were mixed with 100 mL
AgMUNH2 of each different NPs size using a rotary shaker for 3 h at room temperature.
AgMUNH-Oflx NPs were washed with 50 mM PBS using centrifugation .The pellets
were redispersed in 50 mM PBS and stored at 4ºC for future use. The sizes and optical
properties were characterized using UV-vis spectroscopy, DFOMS and DLS.
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Cell Culture and Preparation
The Bacillus subtilis cell lines using in this study are as follows: WT (BmrA) were
purchased from Bacillus Genome Stock Center (BGSC), while ΔBmrA (previously
named as ΔYvcC, mutant strain that is void of the BmrA) were provided by J. M. Jault. 66
We pre-cultured the cells in an Erlenmeyer flask (250 mL) containing 20 mL of Lbroth (LB) medium (1% tryptone peptone, 0.5% yeast extract, and 0.5% NaCl, pH = 7.2)
in a shaker (MaxQ 5000 floor-Model Shaker) (160 rpm, 37C) for 12 h. We then cultured
the cells (WT and ΔBmrA) in the LB medium for another 8 h. We harvested the cultured
cells using centrifugation (Beckman Model J2-21,JA-14 rotor, at 7000 rpm, 23°C, 10
min), washed the cells in PBS buffer three times, and finally re-suspended the cells in
PBS buffer. The final concentration of the cells was adjusted to OD600 nm = 0.7, and used
for the entire study.

Bulk Imaging of Single NPs in Single Living Cells
The cell suspension (OD600nm = 0.7) containing 1.4 nM and 0.7 nM AgMUNH-Oflx
NPs and AgMUNH2 NPs were prepared. The timer was started to record the incubation
time as the NPs were added into the cell suspension. Following NP addition, we
transferred the mixture (1 μL) into a freshly prepared micro-chamber (using nail polish)
every 25 min and using DFOMS we imaged the cells at eighteen representative
locations. This approach permitted us to image the massive amount of cells ( minimum
of 10 cells per location for every 18 locations we usually get 18*10=180 bacteria cells)
for each sample to gain sufficient statistics for probing the accumulation and efflux
kinetics of bulk cells at single cell resolution. We determined intracellular NPs and
plotted them versus time to measure accumulation rates of single NPs for the cells over
time (accumulation rate = slope of the plot).

Cell Viability
At the end of each experiment, the viability of the cells was characterized using
live/dead BacLight bacterial viability and counting assay.46 We imaged the cells using
dark-field optical microscopy and epi-fluorescence microscopy, and counted the green
fluorescence cells (peak wavelength of fluorescence spectra of SYTO9, λmax = 520 nm)
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and red fluorescence cells (peak wavelength of fluorescence spectra of propidium
iodide, λmax = 610 nm) as live and dead cells, respectively.
Data Analysis and Statistics
We acquired eighteen representative images of each cell suspension incubated
with 1.4 or 0.7 nM NPs every 25 min (18 min for imaging and 7 min for the preparation
of slide) for 2 h to study accumulation rates of intracellular NPs in single living cells.
Therefore, a minimal of ~180 cells was imaged every 25 min, and 900 cells were
studied over 2 h for each measurement. Each experiment was repeated three times.
Thus, 2700 cells were studied for each sample, which allowed us to gain sufficient
statistics for probing accumulation rates and efflux kinetics of bulk cells at single cell
resolution. The equilibrium times of accumulation of NPs in the cells were determined at
the times when the accumulation rates of intracellular NPs remained unchanged over
time. The amount of accumulated intracellular NPs for each strain refers to the amount
of intracellular NPs at the equilibrium time.
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CHAPTER VI
STUDY OF EFFLUX FUNCTION OF MULTIDRUG MEMBRANE TRANSPORTERS OF
SINGLE BACILLUS SUBTILIS LIVE CELLS USING 92.0 NM DRUG NANOCARRIERS
INTRODUCTION:
Fluoroquinolone derivatives such as ofloxacin (Oflx) are used in the treatment of
bacterial diseases such pneumonia, chronic bronchitis and urinary tract infection,
however, bacteria have already gained resistance to these drugs. 3,
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Multidrug

membrane resistance (MDR), poses a major problem when treating diseases such as
infections and cancer.5, 52 MDR effluxes toxic or foreign substances out of the cell and is
present in both prokaryotic and eukaryotic cells.3, 52 ATP-binding cassette (ABC) is one
of the largest and most diverse super-families of membrane protein found in living
organisms.3 It is involved in unidirectional transporter, either importing or exporting
substrates such as sugars, ions, lipids and xenobiotic against their concentration
gradients.1, 3-5 ABC transporter has two transmembrane binding domains (TMD) which
selectively bind with substrates or drugs and form the passageway for substrates to
cross membranes and consists two nucleotide-binding domains (NBD).The NBD
hydrolyze ATP which causes the substrates to efflux out of the cell.1, 4-5

The

pore

crystallography.

size

1, 5, 69

of

a

membrane

transporter

is

determined

by

x-ray

However, this method is limited by the crystallization of the

membrane protein and will not provide real-time kinetic information about molecular and
conformational changes. Current methods for the study of MDR measure the
accumulation of radioactively labeled substances such as

14

C or 3H and the fluorescent

dyes such as ethidium bromide and Hoechst dye for uptake and efflux kinetics in both
prokaryotic and eukaryotic cells.6-9 This approach provides the sum of accumulation
kinetics in a cell population (bulk). However, individual single cells act independently.
We used fluorophores and demonstrated that the efflux kinetics of single membrane
transporters of single live cells can be studied in real time using fluorescence
microscopy. However, radio isotopes and fluorophores do not possess size-dependent
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physicochemical properties. This is why they are not used as pump substrates for the
study of size-dependent efflux function of single membrane transporter in live cells.

Among Noble metal nanoparticles, Gold (Au) and Silver (Ag) NPs have
distinctive properties which can be characterized and imaged by far-field dark-field
optical microscope with a halogen lamp illuminator.34, 38, 40, 43-44, 49-50 NPs do not undergo
photo-bleaching or photo-blinking and the localized surface plasmon resonance (LSPR)
spectra of single NPs highly depends upon their sizes, shapes, dielectric constants, and
the surrounding environment.54-58 Through this information, the size of NPs in solution,
in single live cells, and in single embryos can be determined in real time.

34, 38, 40, 43-44, 49-

50

In previous studies, we used LSPR of single Ag NPs in P.aeruginosa ( a gramnegative bacteria) and also in E.coli (a gram-negative bacteria) to study the efflux
function.40 We further studied the size and charge dependent LSPR of single Ag NPs in
single live Bacillus subtilis cells (a gram-positive bacterium).38-39, 65 B.subtilis was used
as a model organism to study the efflux function since 78 ABC transporters have been
identified in this organism.61-63

In this study, we synthesized and characterized the purified Ag NPs 92.6 ± 4.4
nm and then functionalized with Oflx. We used these nano-carriers to the study the
efflux function of single membrane transporter in single B.subtilis cells.

RESULTS AND DISCUSSION
Synthesis of AgMUNH-Oflx (drug nano-carriers)
We synthesized 92.6 ± 4.4 nm Ag NPs as explained in previous papers and
methods.42 Ag NPs were purified and then functionalized with Oflx by a two-step
reaction process. First, the thiol group was functionalized using of MUNH 2. Second, the
carboxyl group of Oflx was linked to the amine group of MUNH2 via the peptide bond.
We then calculated the number of Oflx attached to single NPs and found it to be
6.5x105.60
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Efflux mechanism of AgMUNH-Oflx and AgMUNH2 NPs in B.subtlis
Single AgMUNH-Oflx NPs and AgMUNH2 NPs have localized surface plasma
membrane (LSPR) spectra (colors) to distinguish between cell membranes and debris,
which do not possess plasmonic properties. The LSPR spectra of single NPs allows us
to track and identify intracellular and extracellular single NPs of single live cells (WT and
ΔBmrA) using DFOMS. Representative images of dark-field optical imaging of single
live WT cells (Fig. 36) of AgMUNH-Oflx NPs and AgMUNH2 NPs (Fig. 37) show cross
sections of single rod-like bacterial cells. Intracellular NPs appear dimmer (Fig. 36B) for
AgMUNH-Oflx NPs and (Fig. 37B) for AgMUNH2 NPs since dark-field illumination
passes through the cell membrane to radiate and scatter NPs. Intracellular NPs pass
through the membrane to reach the detector and the cell membrane absorbs and
scatters photons resulting in lowering of the scattering intensity of NPs due to the cell
membrane. On the other side, extracellular NPs appear brighter on the membrane and
stick outside the cells (Fig. 36C) for AgMUNH-Oflx NPs and (Fig. 37C) for AgMUNH2
NPs. We used LSPR distinctive feature to distinguish individual intracellular and
extracellular NPs for the study of efflux kinetics of single membrane transporter in single
live cells in real time.

The representative LSPR spectra of single 92.6 ± 4.4 nm in Figure 36D showed
distinctive plasmonic properties of single AgMUNH-Oflx NP with peak wavelengths
(λmax) at 623 nm and 630 nm. If NPs were not stable they would aggregate and the size
of NPs would increase, leading to a red shift of LSPR spectra and higher scattering
intensity of single NPs. If Oflx or MUNH2 were released or detached from NPs surface,
a blue shift of NPs would have observed. This was not seen, indicating that NPs are
stable in the PBS buffer and in the cell over time.
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Figure 36: Imaging of single intracellular 92.6 ± 4.4 nm AgMUNH-Oflx NPs in
single living B.subtilis bacterial cells using DFOMS.

(A) The representative image of WT bacterial cells incubated with 3.7 pM AgMUNHOflx NPs showing intracellular drug nano-carriers as squared. (B) Zoom-in images of
single WT cells show (i, iii) are CCD images pseudo colors were added and (ii, iv) color
images intracellular AgMUNH-Oflx NPs. (B) Zoom-in images of single cells show (i, iii)
are CCD images pseudo colors were added and (ii, iv) color images extracellular
AgMUNH-Oflx NPs. The scale bar in A and B are 5 and 2 µm, respectively. (D) LSPR
spectra of 92.6 ± 4.4 nm AgMUNH-Oflx NPs show peak wavelength at 623 nm and 630
nm.
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Figure 37: Imaging of single intracellular 92.6 ± 4.4 nm AgMUNH2 NPs in single
living B.subtilis bacterial cells using DFOMS.

(A)The representative image of WT bacterial cells incubated with 3.7 pM AgMUNH2 NPs
showing intracellular nano-carriers as squared. (B) Zoom-in images of single WT cells
show (i, iii) are CCD images pseudo colors were added and (ii, iv) color images
intracellular AgMUNH2 NPs. (B) Zoom-in images of single cells show (i, iii) are CCD
images pseudo colors were added and (ii, iv) color images extracellular AgMUNH 2 NPs.
The scale bar in A and B are 5 and 2 µm.
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Accumulation Rates of Single AgMUNH-Oflx and AgMUNH2 NPs in Single Live
Cells
The accumulation of single NPs were studied in two strains of B.subtilis live cells,
WT cells which normally express of BmrA and ΔBmrA cells with deletion of BmrA, in
real time to characterize the accumulation of intracellular NPs in single cells upon the
expression of BmrA in single live cells, to determine if BmrA are responsible for
extrusion of 92.4 ± 4.4 nm AgMUNH-Oflx NPs out of live cells in same as drug
molecules.

The results as shown in Figure 38A show that WT cells accumulate the
intracellular AgMUNH-Oflx NPs to the same extent as ΔBmrA for 40.5 min. As time
proceeded we were able to see a higher number of intracellular AgMUNH-Oflx NPs in
ΔBmrA cells whereas in WT cells the number of intracellular AgMUNH-Oflx NPs
remained constant. The accumulation rates (slope of the plot) of intracellular AgMUNHOflx NPs were 0.27 and 0.31 NPs/min for WT and ΔBmrA cells respectively for cells
incubated with 3.7 pM at 40.5 min (Table 5). Results from Figure 39A show that WT
cells accumulate the intracellular AgMUNH2 NPs at a slower rate over time than ΔBmrA.
As time lapsed, a similar number of intracellular AgMUNH2 NPs was observed in both
strains, indicating the high dependence of accumulation rate. The accumulation of
intracellular AgMUNH2 NPs was 1.25 and 1.73 NPs/min for WT and ΔBmrA cells
(Table5). Bacteria cells cannot do endocytosis, pinocytosis, or exocytosis and are not
responsible for extruding the NPs. From these two results, we can conclude that
AgMUNH-Oflx NPs are effluxed out at a faster rate leading to less accumulation of
AgMUNH-Oflx NPs in WT when compared with ΔBmrA.

# of Intracellular
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Figure 38: Study of efflux kinetics of BmrA membrane transporter using 92.6 ± 4.4
nm AgMUNH-Oflx NPs.

(A) Plots of number of intracellular AgMUNH-Oflx NPs in B.subtilis incubated with 3.7
pM (a) ΔBmrA and (b) WT. (B) Plots of number of intracellular AgMUNH-Oflx NPs in
B.subtilis incubated with 1.85 pM (a) ΔBmrA and (b) WT.
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Figure 39: Study of efflux kinetics of BmrA membrane transporter using 92.6 ± 4.4
nm AgMUNH2 NPs.
(A) Plots of number of intracellular AgMUNH2 NPs in B.subtilis incubated with 3.7 pM
(a) ΔBmrA and (b) WT (B) Plots of number of intracellular AgMUNH2 NPs in B.subtilis
incubated with 1.85 pM (a) ΔBmrA and (b) WT.

93
Study of Concentration-Dependent Accumulation Rates of Single AgMUNH-Oflx
NPs and AgMUNH2 NPs in Single Live Cells
We studied the concentration-dependence of accumulation rates of single
AgMUNH-Oflx NPs and AgMUNH2 NPs to determine how NPs enter the cells and how
they passively diffuse into cells, similar to conventional pump substrates like antibiotics.
The results in Figure 38, Figure 39 and Table 5 show that the intracellular NPs in single
live cells highly depend on NP concentration for both strains (WT and ΔBmrA). The
number of intracellular NPs increases along with the NP concentration at given
incubation time. The number of intracellular NPs in WT increases at a slower rate than
ΔBmrA. As the concentration of AgMUNH-Oflx NPs increased from 1.85 pM to 3.7 pM ,
the number of intracellular AgMUNH-Oflx NPs increased from 9 to 21 in WT during 41.5
min with an accumulation rates of 0.09 to 0.27 NPs/min respectively. Whereas in
ΔBmrA the number of intracellular AgMUNH-Oflx NPs increased from 16 to 24 during
41.5 min with an accumulation rate 0.19 to 0.31 NPs/min respectively. We also saw
concentration dependence in cells incubated with AgMUNH2 NPs, when the
concentration increased from 1.85 pM to 3.7 pM, the number of intracellular AgMUNH2
NPs increased from 72 to 98 in WT with an accumulation rate of 0.9 to 1.25 NPs/ min.
In ΔBmrA intracellular NPs increased from 69 to 149 NPs with accumulation rate of 0.83
to 1.7 NPs/min.

These results suggest that NPs are transported from the outside to the inside of
the cell by passive diffusion which is similar to antibiotics. They also extrude the NPs
outside of WT cells, leading to a lower accumulation of intracellular NPs than ΔBmrA.

From Figure 40Aa and 40Ab WT cells incubated with (i) AgMUNH-Oflx NPs and
(ii) AgMUNH2 NPs at 3.7 pM and 1.85 pM concentration respectively. From Figure 40
and Table 5 we can conclude that AgMUNH-Oflx NPs are effluxed out at a faster rate
than AgMUNH2 NPs. This has been observed in ΔBmrA cells in Figure 40Bc and 40Bd
as well as.
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Figure 40: Study of concentration-dependent accumulation kinetics of Single 92.6
± 4.4 nm AgMUNH-Oflx NPs and AgMUNH2 NPs in single live cells.
Plots of number of intracellular NPs in (A) WT and (B) ΔBmrA cells that were incubated
with (a, c) (i) 3.7 pM AgMUNH-Oflx NPs, (ii) 3.7 pM AgMUNH2 NPs (b, d) (i) 1.85 pM
AgMUNH-Oflx NPs , (ii) 1.85 pM AgMUNH2 NPs .The points represent the sum of three
repeated experiments.
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Table 5: Study of Accumulation Rates and Number of Intracellular Single NPs in Single
Live Cells

Diameter
(nm)a

C NPs
(pM)
3.7

92.6±4.4
1.85

NPs
AgMUNH-Oflx
AgMUNH2
AgMUNH-Oflx
AgMUNH2

Accumulation
Rate (NPs min-1)b
WT
0.27
1.25
0.09
0.90

ΔBmrA
0.31
1.73
0.19
0.83

Number of
Intracellular NPs
(min)c
WT
Δ BmrA
21
24
98
149
9
16
72
69

a

Diameter of Ag NPs measured by TEM;

b

Accumulation rates (slopes of plots) of the NPs in 900 live cells over 41.5 min (Figure

40);
c

Number of intracellular NPs accumulated in 900 live cells at 41.5 min incubation

It can be concluded that NPs functionalized with a drug molecules are effluxed
out at a much faster rate, leading to lower accumulation rate when compared with
AgMUNH2 NPs. The diffusion rates of NPs into the cells highly depend upon
concentration gradient and type of molecule attached to NPs whereas as efflux out of
cells is an energy driven (ATP) process.

Characterization of Viability of Single Cells
The viability of single cells plays a major role in accumulation studies since NPs
will accumulate more in disintegrated or dead cells which leading to wrong conclusions.
Hence it is important to know the viability of cells hence we used live/dead BacLight
assay which uses two nucleic acid stains. SYTO9 (λmax = 520 nm) a green fluorescent
to stain live cells and propidium iodide (λmax = 610 nm) red fluorescent which stain
disintegrated and dead cells. Green fluorescence cells are counted as live cells and red
fluorescence cells as are counted as dead cells.
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Figure 41: Characterization of the viability of single bacterial cells using live/dead
Baclight viability and counting assay.

(a) Dark-field optical image and (b) fluorescence image of single bacterial cells (A)
ΔBmrA (B) WT cells, incubated with 3.7 pM AgMUNH-Oflx NPs over the duration of
each experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9,
indicating that cells are viable. (C) Plots of percentage of viable cells incubated with (a,
b) 3.7 pM nM AgMUNH-Oflx NPs and (c, d) 1.85 pM AgMUNH-Oflx NPs, indicate that
99-100% of the cells are alive. Minimum 300 cells were assayed and analyzed. The
scale bar is 5 µm.
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Figure 42: Characterization of the viability of single bacterial cells using live/dead
Baclight viability and counting assay.

(a) Dark-field optical image and (b) fluorescence image of single bacterial cells (A)
ΔBmrA (B) WT cells, incubated with 3.7 pM AgMUNH2 NPs over the duration of each
experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, indicating
that cells are viable. (C) Plots of percentage of viable cells incubated with (a, b) 3.7 pM
AgMUNH2 NPs and (c, d) 1.85 pM AgMUNH2 NPs, indicate that 99-100% of the cells
are alive. Minimum 300 cells were assayed and analyzed. The scale bar is 5 µm.
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WT and ΔBmrA cells were incubated with AgMUNH-Oflx NPs and AgMUNH2
NPs for 2 h and then live/dead BacLight assay was used to measure viability at the end
of an experiment by acquiring optical images and fluorescence images of single cells.
Figure 41A and Figure 41B are representative images of ΔBmrA and WT respectively,
Figure 41a is optical images and Figure 41b is green fluorescence with and without
AgMUNH-Oflx NPs in single cells. We calculated the percentage of viable cells by
dividing the number of live cells (green fluorescence) over a total number of cells (green
and red fluorescence). Figure 41C indicates that 99-100% of cells are viable for both
strains and concentration, thus indicating that AgMUNH-Oflx NPs are biocompatible.
Figure 42A and Figure 42B are representative images of ΔBmrA and WT respectively,
Figure 42a is optical images and Figure 42b is green fluorescence with and without
AgMUNH2 NPs in single cells. Figure 42C indicates that 99-100% of cells are viable for
both strains and concentrations, thus indicating that AgMUNH2 NPs are biocompatible.

SUMMARY
In summary, we synthesized and characterized 92.6 ± 4.4 nm Ag NPs and then
functionalized them with Oflx via a peptide bond between the amine group of AgMUNH 2
and the carboxyl group of Oflx in order to synthesize AgMUNH-Oflx NPs. Both
AgMUNH-Oflx and AgMUNH2 are biocompatible with WT and ΔBmrA cells up to the
concentration of 3.7 pM. We demonstrated that nano-carriers can be used as
photostable optical probes to study efflux kinetic in BmrA (ABC) membrane transporter
in a single live cell. The results show high dependence on the type of carrier on the
surface of NPs, the expression level of BmrA, and on the concentration of NPs. The
results show fewer intracellular AgMUNH-Oflx NPs than AgMUNH2 NPs in BmrA cells
which confirms that linking NPs with drug molecules, such as Oflx, causes them to
efflux out much faster than AgMUNH2 NPs. As the concentration of NPs increased, a
higher numbers of intracellular NPs were observed. When comparing strains, the WT
has a smaller number of intracellular NPs when compared with ΔBmrA cells (devoid of
BmrA) indicating strain dependence and that, this can serve in drug delivery. In this
study, we functionalized 6.4x105 Oflx molecules on the surface of NPs.
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METHODS
Reagents and Supplies
Silver

nitrate,

sodium

citrate

dihydrate

(99%),Sodium

chloride,

sodium

phosphate, sodium phosphate monobasic monohydrate, 2-mercaptoethanol (99%), 11mercaptoundecylamine (MUNH2, 99%), were purchased from Sigma-Aldrich. 1-Ethyl-3[3-dimethylaminopropyl]-carbodiimide

hydrochloride

(EDC,

99%)

and

N-

hydroxysulfosuccinimide (sulfo-NHS, 98.5%) were purchased from Pierce. Silver
perchlorate monohydrate (99%) was purchased from Alfa Aesar. Ofloxacin powder
(≥98%) purchased from Enzo life science. Tryptone, yeast extract, and NaCl are
purchased from sigma-Aldrich and live/dead BacLight viability and counting assay were
purchased from Invitrogen. All reagents were used as received. The nanopure water
(18.0 M water, Barnstead) was used to prepare all solutions and rinse glassware.

Synthesis and Characterization of NPs
Synthesize 92.6 ± 4.4 nm Ag NPs, sodium citrate (10 mL, 34 mM) was added
into a refluxing (100 ºC) stirring AgNO3 (500 mL, 3.98 mM) solution which further was
stirring for additional 35 min.42 The heating was stopped to allow the solution to cool
down to room temperature without stirring. Additional sodium citrate (2.5 mM) was
added to the NPs solution for stability purpose. The solution was filtered through 0.22
µm membrane and purified by washing three times with nanopure water using
centrifugation. Characterized using UV-vis spectroscopy (Hitachi U2010), our dark-field
single nanoparticle optical microscopy and spectroscopy (SNOMS), and dynamic light
scattering (DLS) (Nicomp 380ZLS particle sizing system). TEM samples were
immediately prepared and further characterized using high-resolution transmission
electron microscopy (HRTEM) (FEI Tecnai G2 F30 FEG).

Our Dark-field Optical Microscopy (DFOMS) is equipped with a dark-field optical
microscope, which includes a dark-field condenser (oil 1.43–1.20, Nikon) and a 100×
objective (Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth
of field (focus) of 190 nm, a CCD camera (Micromax, Roper Scientific) and Multispectral
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Imaging System (Nuance, CRI).

37, 50

We explained development and application of

DFOMS have been fully described in our previous studies.

35-37, 39-40, 42-44, 48

Synthesis of AgMUNH2 NPs
MUNH2 (100 mM) in 1 mL ethanol was added to 100 mL of 92.6 ± 4.4 nm Ag
NPs solution. The solutions then were stirred for 24 h to attach MUNH 2 onto the surface
of Ag NPs via their interaction of thiol groups with NPs. The AgMUNH 2 NPs were
washed twice by nanopure water to remove excess MUNH2 using centrifugation 25,000
rpm at 4ºC for 20 min. The AgMUNH2 NPs were immediately characterized using UVvis spectroscopy, DFOMS and DLS.

Synthesis of AgMUNH-Ofloxacin NPs (AgMUNH-Oflx)
An amine group of AgMUNH2 NPs was conjugated to a carboxyl group of
ofloxacin via a peptide bond using EDC and sulfo-NHS as mediators.

67-68

Initially,

ofloxacin powder was dissolved in 0.5 M HCl and diluted to 10 mM using MES buffer
(50 mM, pH 5.0). EDC (30 μmol) and sulfo-NHS (150 μmol) were added into the
ofloxacin solution (3 mL, 50 mM) which then was kept stirring for 40 min allowing Oflx-sNHS esters to form. The reaction was stopped by adding 10 μL of 2-mercaptoethanol.
To link AgMUNH2 with Oflx-s-NHS, 1 mL Oflx-s-NHS esters were mixed with 100 mL
AgMUNH2 of each different NPs size using a rotary shaker for 3 h at room temperature.
AgMUNH-Oflx were washed with 50 mM PBS using centrifugation .The pellets were
redispersed in 50 mM PBS and stored at 4ºC for future use. The sizes and optical
properties were characterized using UV-vis spectroscopy, DFOMS and DLS.

Cell Culture and Preparation
The Bacillus subtilis cell lines using in this study are as follows: WT (BmrA) were
purchased from Bacillus Genome Stock Center (BGSC), while ΔBmrA (previously
named as ΔYvcC, a mutant strain that is void of the BmrA) were provided by J. M.
Jault.66
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We pre-cultured the cells in an Erlenmeyer flask (250 mL) containing 20 mL of Lbroth (LB) medium (1% tryptone peptone, 0.5% yeast extract, and 0.5% NaCl, pH = 7.2)
in a shaker (MaxQ 5000 floor-Model Shaker) (160 rpm, 37C) for 12 h. We then cultured
the cells (WT and ΔBmrA) in the LB medium for another 8 h. We harvested the cultured
cells using centrifugation (Beckman Model J2-21,JA-14 rotor, at 7000 rpm, 23°C, 10
min), washed the cells in PBS buffer three times, and finally re-suspended the cells in
PBS buffer. The final concentration of the cells was adjusted to OD600 nm = 0.7, and used
for the entire study.

Bulk Imaging of Single NPs in Single Living Cells
The cell suspension (OD600nm = 0.7) containing 3.7 pM and 1.85 pM AgMUNHOflx NPs and AgMUNH2 NPs were prepared. The timer was started to record the
incubation time as the NPs were added into the cell suspension. Following NP addition,
we transferred the mixture (1 μL) into a freshly prepared micro-chamber (using nail
polish) every 25 min and using DFOMS we imaged the cells at eighteen representative
locations. This approach permitted us to image the massive amount of cells ( minimum
of 10 cells per location for every 18 locations we usually get 18*10=180 bacteria cells)
for each sample to gain sufficient statistics for probing the accumulation and efflux
kinetics of bulk cells at single cell resolution. We determined intracellular NPs and
plotted them versus time to measure accumulation rates of single NPs for the cells over
time (accumulation rate = slope of the plot).
Cell Viability
At the end of each experiment, the viability of the cells was characterized using
live/dead BacLight bacterial viability and counting assay. We imaged the cells using
dark-field optical microscopy and epi-fluorescence microscopy, and counted the green
fluorescence cells (peak wavelength of fluorescence spectra of SYTO9, λmax = 520 nm)
and red fluorescence cells (peak wavelength of fluorescence spectra of propidium
iodide, λmax = 610 nm) as live and dead cells, respectively.
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Data Analysis and Statistics
We acquired eighteen representative images of each cell suspension incubated
with 3.7 or 1.85 pM NPs every 25 min (18 min for imaging and 7 min for the preparation
of slide) for 2 h to study accumulation rates of intracellular NPs in single living cells.
Therefore, a minimal of ~180 cells was imaged every 25 min, and 900 cells were
studied over 2 h for each measurement. Each experiment was repeated three times.
Thus, 2700 cells were studied for each sample, which allowed us to gain sufficient
statistics for probing accumulation rates and efflux kinetics of bulk cells at single cell
resolution. The equilibrium times of accumulation of NPs in the cells were determined at
the times when the accumulation rates of intracellular NPs remained unchanged over
time. The amount of accumulated intracellular NPs for each strain refers to the amount
of intracellular NPs at the equilibrium time.
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CHAPTER VII
CONCLUSION

In summary, this dissertation presents our study of development of Ag NPs for
the study of multidrug ABC membrane transporters (e.g., MsbA and BmrA) in single live
cells and for design of drug nano-carriers to achieve effective therapy, aiming to
understand and overcome MDR. We have studied and found the high dependence of
efflux kinetics of membrane transporters of single live cells upon the sizes of single Ag
NPs and single drug nano-carriers. We have designed and studied the high
dependence of inhibitory effects of drug nano-carriers against bacterial cells (e.g., two
model organisms such as E.coli, B.subtilis). The most significant findings in each
chapter are summarized below.

As we described in Chapter II, we synthesized and characterized purified and
nearly uniform spherical Ag NPs (12.3 ± 1.8 nm in diameter) to study real-time efflux
function of ABC membrane transporters in single live cells. We developed new imaging
approach, such as DFOMS, to study the efflux kinetics and functions of ABC membrane
transporters of single live cells. We used distinctive LSPR spectra of single Ag NPs to
identify and track single NPs in and out of single live cells, and to study the efflux
function of single MsbA membrane transporters in single live cells in real time. We
found that Ag NPs were biocompatible with single live cells and single Ag NPs can be
used to study the efflux kinetics of single MsbA membrane transporters in single live
cells in real time. We found a high-dependent accumulation rates of single Ag NPs in
single live cells upon the concentration of NPs and the presence of the pump inhibitor
(orthovanadate), suggesting that NPs enter cells via passive diffusion, similar to
antibiotics (pump substrates), and extruded out of the cells by MsbA transporters.
These results demonstrate that single plasmonic NPs can serve as unique sizeddependent molecular imaging probes to study efflux functions of single membrane
transporters in single live cells in real-time.
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As described in Chapter III, we synthesized and characterized three different
sized Ag NPs (2.4 ± 0.7 nm, 13.0 ± 3.1 nm and 92.6 ± 4.4 nm), functionalized them with
monolayer of MUNH2, and linked them with antibiotics (Oflx) via two-step reaction
process. First thiol group is used to attach monolayer of MUNH2 molecules to produce
AgMUNH2 NPs, and in step 2, carboxyl group of ofloxacin (Oflx) is covalently
conjugated with the amine group of MUNH2 on the NPs via the peptide bond. We
determined the conjugation ratio (the number of Oflx molecules attached to a single NP)
of 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm as 8.6x102, 9.4x103, and 6.5x105,
respectively. We studied size-dependent biocompatibility and toxicity of drug nanocarriers (AgMUNH-Oflx NPs) in bacterial cells (B.subtilis). We found size-dependent
inhibitory effects of drug nano-carriers against the bacteria cells, and the smaller drug
nano-carriers are much more biocompatible than the larger drug nano-carriers. In other
words, the larger drug nano-carriers show higher inhibitory effects against the bacterial
cells. For example, 2.4 ± 0.7 nm AgMUNH-Oflx NPs is more biocompatible than 13.0 ±
3.1 nm AgMUNH-Oflx NPs. Further, 92.6 ± 4.4 nm AgMUNH-Oflx NPs show higher
inhibitory effects than 13.0 ± 3.1 nm AgMUNH-Oflx NPs. These results demonstrate that
2.4 ± 0.7 nm AgMUNH-Oflx NPs can be used for probing of efflux kinetics and functions
of single ABC membrane transporters in single live cells, while the larger drug nanocarriers (92.6 ± 4.4 nm AgMUNH-Oflx NPs) could be used to enhance efficacy of
antibiotics against bacteria. We used these drug nano-carriers to study efflux functions
of ABC (BmrA) transporters in single live cells (two strains of B.subtilis), WT (normal
expression of BmrA) and ∆BmrA (deletion of BmrA), as described in Chapters IV-VI.

As we described in Chapter IV, we used the smallest drug nano-carriers (2.4 ±
0.7 nm AgMUNH-Oflx NPs) to study the efflux kinetics and functions of ABC (BmrA)
transporters in single live cells (B.subtilis). Interestingly, we did not find the significant
dependence of accumulation kinetics of such small drug nano-carriers upon the dose of
the drug nano-carriers (0.7 and 1.4 nM) for the WT strain, while we observed the
significant dependence of accumulation kinetics of the drug nano-carriers upon the dose
of the drug nano-carriers (0.7 and 1.4 nM) for the ΔBmrA strain. The results show the
high dependence of accumulation kinetics of the drug nano-carriers upon the
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expression of BmrA in single B.subtilis live cells, suggesting that these small drug nanocarriers passively diffused into the live cells and were extruded out of the cells by BmrA,
similar to antibiotics.

As we presented in Chapter V, we used slightly larger drug nano-carriers (13.0 ±
3.1 nm AgMUNH-Oflx NPs) to study the efflux kinetics and functions of BmrA
transporters in single live cells (B.subtilis). Remarkably, unlike the smaller 2.4 ± 0.7 nm
drug nano-carriers, we found the high dependence of accumulation kinetics of the drug
nano-carriers upon the dose of the drug nano-carriers (0.7 and 1.4 nM) for both strains
of BmrA (WT, ΔBmrA) and the expression of BmrA in single live cells. The findings
further suggest that the drug nano-carriers passively diffused into the live cells and were
extruded out of the cells by BmrA, similar to antibiotics. Moreover, the results suggest
that the BmrA could more effectively extrude the smaller drug nano-carriers (2.4 ± 0.7
nm) than the larger drug nano-carriers (13.0 ± 3.1 nm). Therefore, the smaller drug
nano-carriers could be used to study the efflux function of BmrA membrane transporters
in single live cells, while the large drug nano-carriers could be used to effectively deliver
antibiotics that could overcome MDR and enhance antibiotics efficacy.

As we described in Chapter VI, we used the largest drug nano-carriers (92.6 ±
4.4 nm) to study the efflux kinetics and function of BmrA membrane transporter in single
live cells (B.subtilis). Interestingly, like 13.0 ± 3.1 nm drug nano-carriers, we found the
high dependence of accumulation kinetics of the nano-carriers upon the dose of the
drug nano-carriers (1.85 and 3.7 pM) for both strains of BmrA (WT, ΔBmrA), while
insignificant dependence of accumulation kinetics of the drug nano-carriers upon the
expression of BmrA in single live cells. The results demonstrate that such larger nanocarriers passively diffused into the live cells and were ineffectively extruded out of the
cells by BmrA. The largest drug nano-carriers (92.6 ± 4.4 nm) could be least effectively
extruded out of the cells while the smallest drug nano-carriers (2.4 ± 0.7 nm) could be
most effectively extruded out of the cells. Taken together, our study further
demonstrates that the smaller drug nano-carriers could be used to study the efflux
function of BmrA membrane transporters in single live cells, while the large drug nano-
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carriers could be used to effectively deliver antibiotics that could overcome MDR and
enhance antibiotics efficacy.

107
REFERENCES
1.
Higgins, C. F., ABC transporters: physiology, structure and mechanism--an
overview. Res Microbiol 2001, 152, 205-210.
2.
Jones, P. M.; George, A. M., The ABC transporter structure and mechanism:
perspectives on recent research. Cell Mol Life Sci 2004, 61, 682-699.
3.
Alvarez, A. I.; Perez, M.; Prieto, J. G.; Molina, A. J.; Real, R.; Merino, G.,
Fluoroquinolone efflux mediated by ABC transporters. J Pharm Sci 2008, 97, 34833493.
4.
Davis, M. E.; Chen, Z. G.; Shin, D. M., Nanoparticle therapeutics: an emerging
treatment modality for cancer. Nat Rev Drug Discov 2008, 7, 771-782.
5.
Gottesman, M. M.; Ambudkar, S. V., Overview: ABC transporters and human
disease. J Bioenerg Biomembr 2001, 33, 453-458.
6.
Morjani, H.; Aouali, N.; Belhoussine, R.; Veldman, R. J.; Levade, T.; Manfait, M.,
Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in
cytoplasmic droplets. Int J Cancer 2001, 94, 157-165.
7.
Mortimer, P. G.; Piddock, L. J., A comparison of methods used for measuring the
accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and
Staphylococcus aureus. J Antimicrob Chemother 1991, 28, 639-653.
8.
Orelle, C.; Gubellini, F.; Durand, A.; Marco, S.; Levy, D.; Gros, P.; Di Pietro, A.;
Jault, J. M., Conformational change induced by ATP binding in the multidrug ATPbinding cassette transporter BmrA. Biochemistry 2008, 47, 2404-2412.
9.
Steel, C.; Wan, Q.; Xu, X. H., Single live cell imaging of chromosomes in
chloramphenicol-induced filamentous Pseudomonas aeruginosa. Biochemistry 2004,
43, 175-182.
10.
Xu, X.-H. N.; Brownlow, W. J.; Huang, S.; Chen, J., Real-time measurements of
single membrane pump efficiency of single living pseudomonas aeruginosa cells using
fluorescence microscopy and spectroscopy. Biochem. Biophys. Res. Commun. 2003,
305, 79-86.
11.
Huang, T.; Xu, X.-H. N., Synthesis and characterization of tunable rainbow
colored silver nanoparticle solutions using single-nanoparticle plasmonic microscopy
and spectroscopy. J. Mater. Chem. 2010, 20, 9867-9876

108
12.
Kreibig, U.; Vollmer, M., In Optical Properties of Metal Clusters, Springer: Berlin,
1995; 14-123.
13.
Nallathamby, P. D.; Huang, T.; Xu, X.-H. N., Design and characterization of
optical nano rulers of single nanoparticles using optical microscopy and spectroscopy.
Nanoscale 2010, 2, 1715-1722.
14.
Kelly, K. L.; Coronado, E.; Zhao, L. L.; Schatz, G. C., The optical properties of
metal nanoparticles: the influence of size, shape, and dielectric environment. J. Phys.
Chem. B 2003, 107, 668–677.
15.
Browning, L. M.; Lee, K. J.; Huang, T.; Nallathamby, P. D.; Lowman, J.; Xu, X.-H.
N., Random walk of single gold nanoparticles in zebrafish embryos leading to stochastic
toxic effects on embryonic developments. Nanoscale 2009, 1, 138-152.
16.
Lee, K. J.; Nallathamby, P. D.; Browning, L. M.; Osgood, C. J.; Xu, X.-H. N., In
vivo imaging of transport and biocompatibility of single silver nanoparticles in early
development of zebrafish embryos. ACS Nano 2007, 1, 133-143.
17.
Nallathamby, P. D.; Lee, K. J.; Desai, T.; Xu, X.-H. N., Study of multidrug
membrane transporters of single living pseudomonas aeruginosa cells using sizedependent plasmonic nanoparticle optical probes. Biochemistry-Us 2010, 49, 59425953.
18.
Xu, X.-H. N.; Brownlow, W. J.; Kyriacou, S. V.; Wan, Q.; Viola, J. J., Real-time
probing of membrane transport in living microbial cells using single nanoparticle optics
and living cell imaging. Biochemistry-Us 2004, 43, 10400-10413.
19.
Xu, X.-H. N.; Chen, J.; Jeffers, R. B.; Kyriacou, S. V., Direct measurement of
sizes and dynamics of single living membrane transporters using nano-optics. Nano
Lett. 2002, 2, 175-182.
20.
Nallathamby, P. D.; Lee, K. J.; Xu, X.-H. N., Design of stable and uniform single
nanoparticle photonics for in vivo dynamics imaging of nanoenvironments of zebrafish
embryonic fluids. ACS Nano 2008, 2, 1371-1380.
21.
Cherukuri, P. K.; Browning, L. M.; Huang, T.; Xu, X. H. N., Study of Efflux
Function of Multidrug Membrane Transporter in Single Escherichia coli Live Cells Using
Single Nanoparticle Plasmonic Spectroscopy (in preparation).
22.
Cherukuri, P. K.; Ding.F.; Songkiatisak.P.; Huang, T.; Xu, X. H. N., Study of SizeDependence of Inhibitory of Drug Nano-Carrier in Bacillus subtilis (in preparation).

109
23.
Cherukuri, P. K.; Songkiatisak.P.; Huang, T.; Xu, X. H. N., Study of Efflux
Function of Multidrug Membrane Transporters of Single Bacillus Subtilis Live Cells
Using 2.0 nm Drug Nano-Carriers (in preparation).
24.
Cherukuri, P. K.; Songkiatisak.P.; Huang, T.; Xu, X. H. N., Study of Efflux
Function of Multidrug Membrane Transporters of Single Bacillus Subtilis Live Cells
using 13.0 nm Drug Nano-Carriers ( in preparation)

25.
Cherukuri, P. K.; Songkiatisak.P.; Huang, T.; Xu, X. H. N., Study of Efflux
Function of Multidrug Membrane Transporters of Single Bacillus subtilis Live Cells
using 93.0 nm Drug-Nano-Carriers (in preparation).
26.
Reyes, C. L.; Ward, A.; Yu, J.; Chang, G., The structures of MsbA: Insight into
ABC transporter-mediated multidrug efflux. FEBS Lett 2006, 580, 1042-1048.
27.
Cole, S. P., Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking"
ATP-binding cassette (ABC) transporter. J Biol Chem 2014, 289, 30880-30888.
28.
Doerrler, W. T.; Raetz, C. R., ATPase activity of the MsbA lipid flippase of
Escherichia coli. J Biol Chem 2002, 277, 36697-36705.
29.
Eckford, P. D.; Sharom, F. J., Functional characterization of Escherichia coli
MsbA: interaction with nucleotides and substrates. J Biol Chem 2008, 283, 1284012850.
30.
Ding, F.; Lee, K. J.; Vahedi-Faridi, A.; Huang, T.; Xu, X. H., Design and probing
of efflux functions of EGFP fused ABC membrane transporters in live cells using
fluorescence spectroscopy. Anal Bioanal Chem 2011, 400, 223-235.
31.
Ding, F.; Lee, K. J.; Vahedi-Faridi, A.; Yoneyama, H.; Osgood, C. J.; Xu, X. H.,
Design and study of the efflux function of the EGFP fused MexAB-OprM membrane
transporter in Pseudomonas aeruginosa using fluorescence spectroscopy. Analyst
2014, 139, 3088-3096.
32.
Nancy Xu, X. H.; Brownlow, W.; Huang, S.; Chen, J., Single-molecule detection
of efflux pump machinery in Pseudomonas aeruginosa. Biochemical and biophysical
research communications 2003, 305, 79-86.
33.
Reuter, G.; Janvilisri, T.; Venter, H.; Shahi, S.; Balakrishnan, L.; van Veen, H. W.,
The ATP binding cassette multidrug transporter LmrA and lipid transporter MsbA have
overlapping substrate specificities. J Biol Chem 2003, 278, 35193-35198.

110
34.
Xu, X. H.; Brownlow, W. J.; Kyriacou, S. V.; Wan, Q.; Viola, J. J., Real-time
probing of membrane transport in living microbial cells using single nanoparticle optics
and living cell imaging. Biochemistry 2004, 43, 10400-10413.
35.
Huang, T.; Nallathamby, P. D.; Gillet, D.; Xu, X. H., Design and synthesis of
single-nanoparticle optical biosensors for imaging and characterization of single
receptor molecules on single living cells. Anal Chem 2007, 79, 7708-7718.
36.
Kyriacou, S. V.; Brownlow, W. J.; Xu, X. H., Using nanoparticle optics assay for
direct observation of the function of antimicrobial agents in single live bacterial cells.
Biochemistry 2004, 43, 140-147.
37.
Huang, T.; Nallathamby, P. D.; Xu, X. H. N., Photostable Single-molecule
Nanoparticle Optical Biosensors for Real-time Sensing of Single Cytokine Molecules
and their Binding Reactions. J Am Chem Soc 2008, 130, 17095-17105.
38.
Browning, L. M.; Lee, K. J.; Cherukuri, P. K.; Nallathamby, P. D.; Warren, S.;
Jault, J.-M.; Xu, X.-H. N., Single nanoparticle plasmonic spectroscopy for study of the
efflux function of multidrug ABC membrane transporters of single live cells. RSC
Advances 2016, 6, 36794-36802.
39.
Lee, K. J.; Browning, L. M.; Huang, T.; Ding, F.; Nallathamby, P. D.; Xu, X. H.,
Probing of multidrug ABC membrane transporters of single living cells using single
plasmonic nanoparticle optical probes. Anal Bioanal Chem 2010, 397, 3317-3328.
40.
Nallathamby, P. D.; Lee, K. J.; Desai, T.; Xu, X. H., Study of the multidrug
membrane transporter of single living Pseudomonas aeruginosa cells using sizedependent plasmonic nanoparticle optical probes. Biochemistry 2010, 49, 5942-5953.
41.
Lee, K. J.; Browning, L. M.; Nallathamby, P. D.; Xu, X. H., Study of chargedependent transport and toxicity of peptide-functionalized silver nanoparticles using
zebrafish embryos and single nanoparticle plasmonic spectroscopy. Chem Res Toxicol
2013, 26, 904-917.
42.
Lee, K. J.; Nallathamby, P. D.; Browning, L. M.; Osgood, C. J.; Xu, X. H., In vivo
imaging of transport and biocompatibility of single silver nanoparticles in early
development of zebrafish embryos. ACS Nano 2007, 1, 133-143.
43.
Nallathamby, P. D.; Lee, K. J.; Xu, X. H., Design of stable and uniform single
nanoparticle photonics for in vivo dynamics imaging of nanoenvironments of zebrafish
embryonic fluids. ACS Nano 2008, 2, 1371-1380.

111
44.
Xu, X.-H. N.; Chen, J.; Jeffers, R. B.; Kyriacou, S., Direct Measurement of Sizes
and Dynamics of Single Living Membrane Transporters Using Nanooptics. Nano Letters
2002, 2, 175-182.
45.
Ocaktan, A.; Yoneyama, H.; Nakae, T., Use of fluorescence probes to monitor
function of the subunit proteins of the MexA-MexB-oprM drug extrusion machinery in
Pseudomonas aeruginosa. J Biol Chem 1997, 272, 21964-21969.
46.
Berney, M.; Hammes, F.; Bosshard, F.; Weilenmann, H.-U.; Egli, T., Assessment
and Interpretation of Bacterial Viability by Using the LIVE/DEAD BacLight Kit in
Combination with Flow Cytometry. Applied and Environmental Microbiology 2007, 73,
3283-3290.
47.
Lee, K. J.; Browning, L. M.; Nallathamby, P. D.; Desai, T.; Cherukuri, P. K.; Xu,
X. H., In vivo quantitative study of sized-dependent transport and toxicity of single silver
nanoparticles using zebrafish embryos. Chem Res Toxicol 2012, 25, 1029-46.
48.
Browning, L. M.; Lee, K. J.; Huang, T.; Nallathamby, P. D.; Lowman, J. E.; Xu, X.
H., Random walk of single gold nanoparticles in zebrafish embryos leading to stochastic
toxic effects on embryonic developments. Nanoscale 2009, 1, 138-152.
49.
Nallathamby, P. D.; Huang, T.; Xu, X. H., Design and characterization of optical
nanorulers of single nanoparticles using optical microscopy and spectroscopy.
Nanoscale 2010, 2, 1715-1722.
50.
Nallathamby, P. D.; Xu, X. H., Study of cytotoxic and therapeutic effects of stable
and purified silver nanoparticles on tumor cells. Nanoscale 2010, 2, 942-952.
51.
Paton, J. H.; Reeves, D. S., Fluoroquinolone antibiotics. Microbiology,
pharmacokinetics and clinical use. Drugs 1988, 36, 193-228.
52.
Marslin, G.; Revina, A. M.; Khandelwal, V. K.; Balakumar, K.; Sheeba, C. J.;
Franklin, G., PEGylated ofloxacin nanoparticles render strong antibacterial activity
against many clinically important human pathogens. Colloids Surf B Biointerfaces 2015,
132, 62-70.
53.
Reller, L. B.; Weinstein, M.; Jorgensen, J. H.; Ferraro, M. J., Antimicrobial
Susceptibility Testing: A Review of General Principles and Contemporary Practices.
Clinical Infectious Diseases 2009, 49, 1749-1755.
54.
Dos Santos, C. A.; Seckler, M. M.; Ingle, A. P.; Gupta, I.; Galdiero, S.; Galdiero,
M.; Gade, A.; Rai, M., Silver nanoparticles: therapeutical uses, toxicity, and safety
issues. J Pharm Sci 2014, 103, 1931-1944.

112
55.
Kelly, K. L.; Coronado, E.; Zhao, L. L.; Schatz, G. C., The Optical Properties of
Metal Nanoparticles: The Influence of Size, Shape, and Dielectric Environment. The
Journal of Physical Chemistry B 2003, 107, 668-677.
56.
Kreibig, U.; Vollmer, M., Optical Properties of Metal Clusters. Springer: Berlin,
1995; p 14-123.
57.
Quang Huy, T.; Van Quy, N.; Anh-Tuan, L., Silver nanoparticles: synthesis,
properties, toxicology, applications and perspectives. Advances in Natural Sciences:
Nanoscience and Nanotechnology 2013, 4, 033001.
58.
You, C.; Han, C.; Wang, X.; Zheng, Y.; Li, Q.; Hu, X.; Sun, H., The progress of
silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity.
Mol Biol Rep 2012, 39, 9193-9201.
59.
Huang, T.; Browning, L. M.; Xu, X. H., Far-field photostable optical nanoscopy
(PHOTON) for real-time super-resolution single-molecular imaging of signaling
pathways of single live cells. Nanoscale 2012, 4, 2797-2812.
60.
Ding.F.; Cherukuri, P. K.; Songkiatisak.P.; Huang, T.; X.H.N., X., Study of SizeDependent Inhibitory Effects of Drug Nano-carriers against Pseudomonas aeruginosa
(to be submitted).
61.
Aguilar, C.; Vlamakis, H.; Losick, R.; Kolter, R., Thinking about Bacillus subtilis
as a multicellular organism. Curr Opin Microbiol 2007, 10, 638-643.
62.
Quentin, Y.; Fichant, G.; Denizot, F., Inventory, assembly and analysis of Bacillus
subtilis ABC transport systems. Journal of molecular biology 1999, 287, 467-484.
63.
Volker, U.; Hecker, M., From genomics via proteomics to cellular physiology of
the Gram-positive model organism Bacillus subtilis. Cell Microbiol 2005, 7, 1077-1085.
64.
Mueller, M.; de la Pena, A.; Derendorf, H., Issues in pharmacokinetics and
pharmacodynamics of anti-infective agents: kill curves versus MIC. Antimicrobial agents
and chemotherapy 2004, 48, 369-377.
65.
Browning, L. M.; Lee, K. J.; Nallathamby, P. D.; Cherukuri, P. K.; Huang, T.;
Warren, S.; Xu, X.-H. N., Single Nanoparticle Plasmonic Spectroscopy for Study of
Charge-Dependent Efflux Function of Multidrug ABC Transporters of Single Live
Bacillus subtilis Cells. The Journal of Physical Chemistry C 2016.

113
66.
Steinfels, E.; Orelle, C.; Fantino, J. R.; Dalmas, O.; Rigaud, J. L.; Denizot, F.; Di
Pietro, A.; Jault, J. M., Characterization of YvcC (BmrA), a multidrug ABC transporter
constitutively expressed in Bacillus subtilis. Biochemistry 2004, 43, 7491-7502.
67.
Lomant, A. J.; Fairbanks, G., Chemical probes of extended biological structures:
synthesis and properties of the cleavable protein cross-linking reagent
[35S]dithiobis(succinimidyl propionate). Journal of molecular biology 1976, 104, 243261.
68.
Staros, J. V.; Wright, R. W.; Swingle, D. M., Enhancement by Nhydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions.
Analytical biochemistry 1986, 156, 220-222.
69.
Locher, K. P.; Lee, A. T.; Rees, D. C., The E. coli BtuCD structure: a framework
for ABC transporter architecture and mechanism. Science 2002, 296, 1091-1098.

114
APPENDIX
When using nanoparticles, standard laboratory practices regarding the use
of hazardous chemicals are followed. The following work practice is required when
handling nanoparticles to reduce potential exposure and ensure safe conditions in
our laboratories. Lab coats must be worn or arm sleeves are required where high
levels of exposure or splashes of solutions containing nanoparticles are
anticipated. Eye protection, where appropriate to the tasks performed is required.
This may include safety glasses, face shields, and/or chemical splash goggles.
Gloves (disposable) are worn at all times when handling nanomaterials.
Appropriate personal clothing is required in all laboratories. Long pants and closed
toed shoes are required. Hand washing facilities are provided in all labs and hand
washing must be performed after handling nanomaterials. All solutions are
disposed of as hazardous waste following established guidelines of the
environmental health and safety office.
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